,date,title,url
0,2001-04-23,广州药业年报,/disclosure/listedinfo/announcement/c/600332_2000_0.pdf
1,2001-05-16,广州药业上市公司章程,/disclosure/listedinfo/announcement/c/600332_2001_g.pdf
2,2001-08-20,广州药业半年报,/disclosure/listedinfo/announcement/c/600332_2001_1.pdf
3,2001-09-28,广州药业关联交易备查,/disclosure/listedinfo/announcement/c/600332_20010928_1.pdf
4,2002-04-06,广州药业总经理工作细则,/disclosure/listedinfo/announcement/c/600332_20020406_7.pdf
5,2002-04-06,广州药业章程修改议案,/disclosure/listedinfo/announcement/c/600332_20020406_6.pdf
6,2002-04-06,广州药业信息披露管理办法,/disclosure/listedinfo/announcement/c/600332_20020406_5.pdf
7,2002-04-06,广州药业监事会议事规则,/disclosure/listedinfo/announcement/c/600332_20020406_4.pdf
8,2002-04-06,广州药业股东大会议事规则,/disclosure/listedinfo/announcement/c/600332_20020406_3.pdf
9,2002-04-06,广州药业独立董事工作制度,/disclosure/listedinfo/announcement/c/600332_20020406_2.pdf
10,2002-04-06,广州药业董事会议事规则,/disclosure/listedinfo/announcement/c/600332_20020406_1.pdf
11,2002-04-08,广州药业年报（修订版）,/disclosure/listedinfo/announcement/c/600332_2001_n.pdf
12,2002-04-19,广州药业年报补充公告,/disclosure/listedinfo/announcement/c/600332_20020419_1.pdf
13,2002-04-29,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/600332_2002_1.pdf
14,2002-06-01,广州药业回访报告,/disclosure/listedinfo/announcement/c/600332_20020601_1.pdf
15,2002-08-19,广州药业半年报,/disclosure/listedinfo/announcement/c/2002-08-19/600332_2002_z.pdf
16,2002-10-28,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-28/600332_2002_3.pdf
17,2002-11-02,广州药业上市公司章程,/disclosure/listedinfo/announcement/c/2002-11-02/600332_20021102_g.pdf
18,2003-03-24,广州药业年报,/disclosure/listedinfo/announcement/c/2003-03-24/600332_2002_n.pdf
19,2003-04-28,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-28/600332_2003_1.pdf
20,2003-05-15,广州药业回访报告,/disclosure/listedinfo/announcement/c/2003-05-15/600332_20030515_1.pdf
21,2003-05-17,广州药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-05-17/600332_20030517_1.pdf
22,2003-08-18,广州药业半年报,/disclosure/listedinfo/announcement/c/2003-08-18/600332_2003_z.pdf
23,2003-10-29,广州药业董事会薪酬与考核委员会实施细则,/disclosure/listedinfo/announcement/c/2003-10-29/600332_20031029_2.pdf
24,2003-10-29,广州药业董事会投资管理委员会实施细则,/disclosure/listedinfo/announcement/c/2003-10-29/600332_20031029_1.pdf
25,2003-10-29,广州药业董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/2003-10-29/600332_20031029_3.pdf
26,2003-10-29,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-29/600332_2003_3.pdf
27,2004-02-09,广州药业召开股东大会通知,/disclosure/listedinfo/announcement/c/2004-02-09/600332_20040209_3.pdf
28,2004-02-09,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-02-09/600332_20040209_2.pdf
29,2004-02-09,广州药业关联交易公告,/disclosure/listedinfo/announcement/c/2004-02-09/600332_20040209_5.pdf
30,2004-02-09,广州药业关联交易公告,/disclosure/listedinfo/announcement/c/2004-02-09/600332_20040209_6.pdf
31,2004-02-09,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-02-09/600332_20040209_1.pdf
32,2004-02-09,广州药业避免同业竞争协议公告,/disclosure/listedinfo/announcement/c/2004-02-09/600332_20040209_4.pdf
33,2004-03-29,广州药业年报,/disclosure/listedinfo/announcement/c/2004-03-29/600332_2003_n.pdf
34,2004-03-29,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-03-29/600332_20040329_2.pdf
35,2004-03-29,广州药业关于持续性关联交易公告,/disclosure/listedinfo/announcement/c/2004-03-29/600332_20040329_3.pdf
36,2004-03-29,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-03-29/600332_20040329_1.pdf
37,2004-03-29,广州药业2004年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-03-29/600332_20040329_4.pdf
38,2004-04-16,广州药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2004-04-16/600332_20040416_1.pdf
39,2004-04-16,广州药业董事会议事规则,/disclosure/listedinfo/announcement/c/2004-04-16/600332_20040416_2.pdf
40,2004-04-29,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-29/600332_20040429_2.pdf
41,2004-04-29,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-29/600332_20040429_1.pdf
42,2004-04-29,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-29/600332_2004_1.pdf
43,2004-06-11,广州药业2003年度股东周年大会会议资料,/disclosure/listedinfo/announcement/c/2004-06-11/600332_20040611_1.pdf
44,2004-06-12,广州药业2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-06-12/600332_20040614_2.pdf
45,2004-06-14,广州药业2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-06-14/600332_20040614_1.pdf
46,2004-06-21,广州药业2003年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2004-06-21/600332_20040621_1.pdf
47,2004-06-24,广州药业关于董事辞任的公告,/disclosure/listedinfo/announcement/c/2004-06-24/600332_20040624_1.pdf
48,2004-07-15,广州药业2004年上半年业绩预警公告,/disclosure/listedinfo/announcement/c/2004-07-15/600332_20040715_1.pdf
49,2004-08-30,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-30/600332_20040830_2.pdf
50,2004-08-30,广州药业关联交易公告,/disclosure/listedinfo/announcement/c/2004-08-30/600332_20040830_3.pdf
51,2004-08-30,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-30/600332_20040830_1.pdf
52,2004-08-30,广州药业半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-30/600332_2004_zzy.pdf
53,2004-08-30,广州药业半年报,/disclosure/listedinfo/announcement/c/2004-08-30/600332_2004_z.pdf
54,2004-09-10,广州药业关于董事辞任的公告,/disclosure/listedinfo/announcement/c/2004-09-10/600332_20040910_2.pdf
55,2004-09-10,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-09-10/600332_20040910_1.pdf
56,2004-09-15,广州药业召开临时股东大会的通告,/disclosure/listedinfo/announcement/c/2004-09-15/600332_20040915_1.pdf
57,2004-10-28,广州药业2004年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-10-28/600332_20041028_1.pdf
58,2004-10-29,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-29/600332_2004_3.pdf
59,2004-11-02,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-11-02/600332_20041102_2.pdf
60,2004-11-02,广州药业2004年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-11-02/600332_20041102_1.pdf
61,2004-11-02,广州药业2004年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-11-02/600332_20041102_3.pdf
62,2004-11-09,广州药业关于子公司增资事项的公告,/disclosure/listedinfo/announcement/c/2004-11-09/600332_20041109_2.pdf
63,2004-11-09,广州药业关于关联交易的公告,/disclosure/listedinfo/announcement/c/2004-11-09/600332_20041109_3.pdf
64,2004-11-09,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-11-09/600332_20041109_1.pdf
65,2004-11-15,广州药业关于召开内资股股东之类别股东大会通告,/disclosure/listedinfo/announcement/c/2004-11-15/600332_20041115_3.pdf
66,2004-11-15,广州药业关于召开临时股东大会通告,/disclosure/listedinfo/announcement/c/2004-11-15/600332_20041115_1.pdf
67,2004-11-15,广州药业关于召开境外上市外资股股东之类别股东大会通告,/disclosure/listedinfo/announcement/c/2004-11-15/600332_20041115_2.pdf
68,2004-11-29,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-11-29/600332_20041129_1.pdf
69,2004-12-14,广州药业关于召开境外上市外资股股东之类别股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2004-12-14/600332_20041214_1.pdf
70,2004-12-28,广州药业2004年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-12-28/600332_20041228_1.pdf
71,2004-12-31,广州药业内资股股东之类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-12-31/600332_20041231_3.pdf
72,2004-12-31,广州药业境外上市外资股股东之类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-12-31/600332_20041231_2.pdf
73,2004-12-31,广州药业2004年第三次临时和关于H股、内资股类别股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2004-12-31/600332_20041231_4.pdf
74,2004-12-31,广州药业2004年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-12-31/600332_20041231_1.pdf
75,2005-04-14,广州药业公告,/disclosure/listedinfo/announcement/c/2005-04-14/600332_20050414_1.pdf
76,2005-04-28,广州药业年报摘要,/disclosure/listedinfo/announcement/c/2005-04-28/600332_2004_nzy.pdf
77,2005-04-28,广州药业年报,/disclosure/listedinfo/announcement/c/2005-04-28/600332_2004_n.pdf
78,2005-04-28,广州药业监事会议事规则,/disclosure/listedinfo/announcement/c/2005-04-28/600332_20050428_3.pdf
79,2005-04-28,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-28/600332_20050428_5.pdf
80,2005-04-28,广州药业关于董事辞职公告,/disclosure/listedinfo/announcement/c/2005-04-28/600332_20050428_6.pdf
81,2005-04-28,广州药业关于持续关联交易的公告,/disclosure/listedinfo/announcement/c/2005-04-28/600332_20050428_8.pdf
82,2005-04-28,广州药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2005-04-28/600332_20050428_2.pdf
83,2005-04-28,广州药业董事会议事规则,/disclosure/listedinfo/announcement/c/2005-04-28/600332_20050428_1.pdf
84,2005-04-28,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-28/600332_20050428_4.pdf
85,2005-04-28,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-28/600332_2005_1.pdf
86,2005-04-28,广州药业2005年上半年业绩预增公告,/disclosure/listedinfo/announcement/c/2005-04-28/600332_20050428_7.pdf
87,2005-05-13,广州药业召开2004年度股东大会的通告,/disclosure/listedinfo/announcement/c/2005-05-13/600332_20050513_1.pdf
88,2005-06-28,广州药业2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-06-28/600332_20050628_1.pdf
89,2005-07-01,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-07-01/600332_20050701_2.pdf
90,2005-07-01,广州药业2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-07-01/600332_20050701_1.pdf
91,2005-07-01,广州药业2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-07-01/600332_20050701_3.pdf
92,2005-07-13,广州药业2004年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2005-07-13/600332_20050713_1.pdf
93,2005-08-02,广州药业关于召开2005年第一次临时股东大会的通告,/disclosure/listedinfo/announcement/c/2005-08-02/600332_20050802_2.pdf
94,2005-08-02,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-08-02/600332_20050802_1.pdf
95,2005-08-15,广州药业半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-15/600332_2005_zzy.pdf
96,2005-08-15,广州药业半年报,/disclosure/listedinfo/announcement/c/2005-08-15/600332_2005_z.pdf
97,2005-09-15,广州药业2005年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-09-15/600332_20050915_1.pdf
98,2005-09-17,广州药业2005年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-09-17/600332_20050917_1.pdf
99,2005-09-19,广州药业2005年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-09-19/600332_20050919_1.pdf
100,2005-10-28,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-28/600332_2005_3.pdf
101,2005-10-28,广州药业2005年度业绩预增公告,/disclosure/listedinfo/announcement/c/2005-10-28/600332_20051028_1.pdf
102,2005-11-16,广州药业公告,/disclosure/listedinfo/announcement/c/2005-11-16/600332_20051116_1.pdf
103,2006-01-19,广州药业2005年度业绩预增公告,/disclosure/listedinfo/announcement/c/2006-01-19/600332_20060119_1.pdf
104,2006-02-24,广州药业关于关联交易的公告,/disclosure/listedinfo/announcement/c/2006-02-24/600332_20060224_1.pdf
105,2006-03-06,广州药业关于进行股权分置改革的提示性公告,/disclosure/listedinfo/announcement/c/2006-03-06/600332_20060306_1.pdf
106,2006-03-15,广州药业关于召开A股市场相关股东会议的公告,/disclosure/listedinfo/announcement/c/2006-03-15/600332_20060315_1.pdf
107,2006-03-15,广州药业股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-03-15/600332_20060315_4.pdf
108,2006-03-15,广州药业股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-03-15/600332_20060315_3.pdf
109,2006-03-15,广州药业股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-03-15/600332_20060315_2.pdf
110,2006-03-15,广州药业股权分置改革方案之独立董事意见,/disclosure/listedinfo/announcement/c/2006-03-15/600332_20060315_6.pdf
111,2006-03-15,广州药业股权分置改革法律意见书,/disclosure/listedinfo/announcement/c/2006-03-15/600332_20060315_5.pdf
112,2006-03-15,广州药业董事会关于征集股权分置改革投票委托的函,/disclosure/listedinfo/announcement/c/2006-03-15/600332_20060315_7.pdf
113,2006-03-16,广州药业关于举行股权分置改革网上交流会的提示性公告,/disclosure/listedinfo/announcement/c/2006-03-16/600332_20060316_1.pdf
114,2006-03-24,广州药业关于股权分置改革方案沟通协商情况暨修改股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2006-03-24/600332_20060324_1.pdf
115,2006-03-24,广州药业股权分置改革之补充保荐意见书,/disclosure/listedinfo/announcement/c/2006-03-24/600332_20060324_4.pdf
116,2006-03-24,广州药业股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-03-24/600332_20060324_3.pdf
117,2006-03-24,广州药业股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-03-24/600332_20060324_2.pdf
118,2006-03-24,广州药业股权分置改革方案之独立董事补充意见,/disclosure/listedinfo/announcement/c/2006-03-24/600332_20060324_6.pdf
119,2006-03-24,广州药业股权分置改革补充法律意见书,/disclosure/listedinfo/announcement/c/2006-03-24/600332_20060324_5.pdf
120,2006-03-27,广州药业关于召开A股市场相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-03-27/600332_20060327_1.pdf
121,2006-04-03,广州药业年报摘要,/disclosure/listedinfo/announcement/c/2006-04-03/600332_2005_nzy.pdf
122,2006-04-03,广州药业年报,/disclosure/listedinfo/announcement/c/2006-04-03/600332_2005_n.pdf
123,2006-04-03,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-03/600332_20060403_2.pdf
124,2006-04-03,广州药业关于控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2006-04-03/600332_20060403_3.pdf
125,2006-04-03,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-03/600332_20060403_1.pdf
126,2006-04-05,广州药业关于召开A股市场相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-04-05/600332_20060405_1.pdf
127,2006-04-07,广州药业关于股权分置改革方案获国资委批准的公告,/disclosure/listedinfo/announcement/c/2006-04-07/600332_20060407_1.pdf
128,2006-04-13,广州药业A股市场相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2006-04-13/600332_20060413_1.pdf
129,2006-04-13,广州药业A股市场股权分置改革相关股东会议法律意见书,/disclosure/listedinfo/announcement/c/2006-04-13/600332_20060413_2.pdf
130,2006-04-19,广州药业股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2006-04-19/600332_20060419_1.pdf
131,2006-04-28,G广药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-28/600332_20060428_2.pdf
132,2006-04-28,G广药关于召开2005年年度股东大会的通告,/disclosure/listedinfo/announcement/c/2006-04-28/600332_20060428_4.pdf
133,2006-04-28,G广药关于董事辞任的公告,/disclosure/listedinfo/announcement/c/2006-04-28/600332_20060428_3.pdf
134,2006-04-28,G广药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-28/600332_20060428_1.pdf
135,2006-04-28,G广药第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-28/600332_2006_1.pdf
136,2006-05-17,G广药公告,/disclosure/listedinfo/announcement/c/2006-05-17/600332_20060517_1.pdf
137,2006-06-08,G广药2005年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-06-08/600332_20060608_1.pdf
138,2006-06-16,G广药关于董事辞任的公告,/disclosure/listedinfo/announcement/c/2006-06-16/600332_20060616_3.pdf
139,2006-06-16,G广药关于持续关联交易的公告,/disclosure/listedinfo/announcement/c/2006-06-16/600332_20060616_4.pdf
140,2006-06-16,G广药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-06-16/600332_20060616_2.pdf
141,2006-06-16,G广药2005年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-06-16/600332_20060616_1.pdf
142,2006-06-16,G广药2005年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-06-16/600332_20060616_5.pdf
143,2006-06-26,G广药2005年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2006-06-26/600332_20060626_1.pdf
144,2006-07-27,G广药公告,/disclosure/listedinfo/announcement/c/2006-07-27/600332_20060727_2.pdf
145,2006-07-27,G广药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-07-27/600332_20060727_1.pdf
146,2006-08-28,G广药半年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2006-08-28/600332_2006_zzy.pdf
147,2006-08-28,G广药半年报,/disclosure/listedinfo/announcement/c/2006-08-28/600332_2006_z.pdf
148,2006-08-31,G广药更正公告,/disclosure/listedinfo/announcement/c/2006-08-31/600332_20060831_1.pdf
149,2006-10-27,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-27/600332_2006_3.pdf
150,2007-01-11,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-01-11/600332_20070111_2.pdf
151,2007-01-11,广州药业关于增持子公司股权及两间子公司合并的公告,/disclosure/listedinfo/announcement/c/2007-01-11/600332_20070111_3.pdf
152,2007-01-11,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-01-11/600332_20070111_1.pdf
153,2007-01-16,广州药业公告,/disclosure/listedinfo/announcement/c/2007-01-16/600332_20070116_1.pdf
154,2007-01-30,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-01-30/600332_20070130_2.pdf
155,2007-01-30,广州药业关于两子公司转让所持另一子公司――广州医药有限公司股权及广州医药有限公司增资事项的公告,/disclosure/listedinfo/announcement/c/2007-01-30/600332_20070130_3.pdf
156,2007-01-30,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-01-30/600332_20070130_1.pdf
157,2007-02-12,广州药业公告,/disclosure/listedinfo/announcement/c/2007-02-12/600332_20070212_1.pdf
158,2007-02-14,广州药业关于召开2007年第一次内资股股东之类别股东大会的通告,/disclosure/listedinfo/announcement/c/2007-02-14/600332_20070214_3.pdf
159,2007-02-14,广州药业关于召开2007年第一次临时股东大会的通告,/disclosure/listedinfo/announcement/c/2007-02-14/600332_20070214_1.pdf
160,2007-02-14,广州药业关于召开2007年第一次境外上市外资股股东之类别股东大会的通告,/disclosure/listedinfo/announcement/c/2007-02-14/600332_20070214_2.pdf
161,2007-03-16,广州药业关于召开2007年第一次境外上市外资股股东之类别股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2007-03-16/600332_20070316_1.pdf
162,2007-03-21,广州药业关于广州医药集团有限公司减持公司股份的权益变动报告书,/disclosure/listedinfo/announcement/c/2007-03-21/600332_20070321_2.pdf
163,2007-03-21,广州药业关于广州北城农村信用合作社持有公司股份的简式权益变动报告书,/disclosure/listedinfo/announcement/c/2007-03-21/600332_20070321_1.pdf
164,2007-03-28,广州药业2007年第一次临时股东大会、境外上市外资股股东之类别股东大会及内资股股东之类别股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-03-28/600332_20070328_1.pdf
165,2007-03-29,广州药业股东关于权益变动报告书的更正公告,/disclosure/listedinfo/announcement/c/2007-03-29/600332_20070329_1.pdf
166,2007-03-30,广州药业公告,/disclosure/listedinfo/announcement/c/2007-03-30/600332_20070330_1.pdf
167,2007-04-03,广州药业内资股股东之类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-04-03/600332_20070403_3.pdf
168,2007-04-03,广州药业境外上市外资股股东之类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-04-03/600332_20070403_2.pdf
169,2007-04-03,广州药业2007年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-04-03/600332_20070403_1.pdf
170,2007-04-03,广州药业2007第一次临时股东大会、H股和内资股类别股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-04-03/600332_20070403_4.pdf
171,2007-04-19,广州药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-04-19/600332_20070419_1.pdf
172,2007-04-30,广州药业与控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2007-04-30/600332_20070430_4.pdf
173,2007-04-30,广州药业年报摘要,/disclosure/listedinfo/announcement/c/2007-04-30/600332_2006_nzy.pdf
174,2007-04-30,广州药业年报,/disclosure/listedinfo/announcement/c/2007-04-30/600332_2006_n.pdf
175,2007-04-30,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-30/600332_20070430_2.pdf
176,2007-04-30,广州药业关于召开2006年年度股东大会的通告,/disclosure/listedinfo/announcement/c/2007-04-30/600332_20070430_3.pdf
177,2007-04-30,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-30/600332_20070430_1.pdf
178,2007-04-30,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-30/600332_2007_1.pdf
179,2007-05-24,广州药业公告,/disclosure/listedinfo/announcement/c/2007-05-24/600332_20070524_1.pdf
180,2007-06-13,广州药业2006年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-06-13/600332_20070613_1.pdf
181,2007-06-18,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-18/600332_20070618_3.pdf
182,2007-06-18,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-18/600332_20070618_2.pdf
183,2007-06-18,广州药业2006年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-06-18/600332_20070618_1.pdf
184,2007-06-18,广州药业2006年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-06-18/600332_20070618_4.pdf
185,2007-06-26,广州药业2006年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2007-06-26/600332_20070626_1.pdf
186,2007-06-30,广州药业信息披露管理制度,/disclosure/listedinfo/announcement/c/2007-06-30/600332_20070630_3.pdf
187,2007-06-30,广州药业公司治理自查报告和整改计划,/disclosure/listedinfo/announcement/c/2007-06-30/600332_20070630_2.pdf
188,2007-06-30,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-30/600332_20070630_1.pdf
189,2007-08-02,广州药业关于主要交易进展情况的公告,/disclosure/listedinfo/announcement/c/2007-08-02/600332_20070802_1.pdf
190,2007-08-07,广州药业H股公告,/disclosure/listedinfo/announcement/c/2007-08-07/600332_20070807_2.pdf
191,2007-08-07,广州药业H股公告,/disclosure/listedinfo/announcement/c/2007-08-07/600332_20070807_1.pdf
192,2007-08-20,广州药业半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-20/600332_2007_zzy.pdf
193,2007-08-20,广州药业半年报,/disclosure/listedinfo/announcement/c/2007-08-20/600332_2007_z.pdf
194,2007-10-29,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-29/600332_20071029_2.pdf
195,2007-10-29,广州药业公司治理整改情况报告,/disclosure/listedinfo/announcement/c/2007-10-29/600332_20071029_3.pdf
196,2007-10-29,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-29/600332_20071029_1.pdf
197,2007-10-29,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-29/600332_2007_3.pdf
198,2007-10-30,广州药业更正公告,/disclosure/listedinfo/announcement/c/2007-10-30/600332_20071030_1.pdf
199,2007-10-30,广州药业第三季度季报（修订版）,/disclosure/listedinfo/announcement/c/2007-10-30/600332_2007_3.pdf
200,2007-12-17,广州药业关于股东减持公司股份的公告,/disclosure/listedinfo/announcement/c/2007-12-17/600332_20071217_1.pdf
201,2008-01-29,广州药业关于重大交易完成的公告,/disclosure/listedinfo/announcement/c/2008-01-29/600332_20080129_1.pdf
202,2008-03-03,广州药业公告,/disclosure/listedinfo/announcement/c/2008-03-03/600332_20080303_1.pdf
203,2008-03-31,广州药业与控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2008-03-31/600332_20080331_4.pdf
204,2008-03-31,广州药业审核委员会年报工作规程,/disclosure/listedinfo/announcement/c/2008-03-31/600332_20080331_5.pdf
205,2008-03-31,广州药业年报摘要,/disclosure/listedinfo/announcement/c/2008-03-31/600332_2007_nzy.pdf
206,2008-03-31,广州药业年报,/disclosure/listedinfo/announcement/c/2008-03-31/600332_2007_n.pdf
207,2008-03-31,广州药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-31/600332_20080331_2.pdf
208,2008-03-31,广州药业关于持续关联交易的公告,/disclosure/listedinfo/announcement/c/2008-03-31/600332_20080331_3.pdf
209,2008-03-31,广州药业独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2008-03-31/600332_20080331_6.pdf
210,2008-03-31,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-31/600332_20080331_1.pdf
211,2008-04-14,广州药业关于召开2007年年度股东大会的通告,/disclosure/listedinfo/announcement/c/2008-04-14/600332_20080414_1.pdf
212,2008-04-14,广州药业H股通函,/disclosure/listedinfo/announcement/c/2008-04-14/600332_20080414_2.pdf
213,2008-04-18,广州药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2008-04-18/600332_20080418_1.pdf
214,2008-04-30,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-30/600332_2008_1.pdf
215,2008-05-23,广州药业2007年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-05-23/600332_20080523_1.pdf
216,2008-05-30,广州药业2007年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-05-30/600332_20080530_1.pdf
217,2008-05-30,广州药业2007年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-05-30/600332_20080530_2.pdf
218,2008-06-10,广州药业2007年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2008-06-10/600332_20080610_1.pdf
219,2008-07-01,广州药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-07-01/600332_20080701_1.pdf
220,2008-07-31,广州药业关于公司治理整改情况的说明,/disclosure/listedinfo/announcement/c/2008-07-31/600332_20080731_2.pdf
221,2008-07-31,广州药业第四届第八次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2008-07-31/600332_20080731_1.pdf
222,2008-08-11,广州药业关于防范控股股东及关联方资金占用的管理办法,/disclosure/listedinfo/announcement/c/2008-08-11/600332_20080811_2.pdf
223,2008-08-11,广州药业第四届第九次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2008-08-11/600332_20080811_1.pdf
224,2008-08-29,广州药业董事会战略发展与投资委员会实施细则,/disclosure/listedinfo/announcement/c/2008-08-29/600332_20080829_4.pdf
225,2008-08-29,广州药业董事会预算委员会实施细则,/disclosure/listedinfo/announcement/c/2008-08-29/600332_20080829_3.pdf
226,2008-08-29,广州药业董事会提名与薪酬委员会实施细则,/disclosure/listedinfo/announcement/c/2008-08-29/600332_20080829_2.pdf
227,2008-08-29,广州药业第四届第十次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2008-08-29/600332_20080829_1.pdf
228,2008-08-29,广州药业半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-29/600332_2008_zzy.pdf
229,2008-08-29,广州药业半年报,/disclosure/listedinfo/announcement/c/2008-08-29/600332_2008_z.pdf
230,2008-09-23,广州药业关于控股股东增持公司股份公告,/disclosure/listedinfo/announcement/c/2008-09-23/600332_20080923_1.pdf
231,2008-10-10,广州药业H股公告,/disclosure/listedinfo/announcement/c/2008-10-10/600332_20081010_1.pdf
232,2008-10-31,广州药业第四届第十二次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2008-10-31/600332_20081031_1.pdf
233,2008-10-31,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-31/600332_2008_3.pdf
234,2008-12-23,广州药业H股股价及成交量的不寻常变动,/disclosure/listedinfo/announcement/c/2008-12-23/600332_20081223_1.pdf
235,2009-02-06,广州药业关于股权分置改革保荐代表人变更的公告,/disclosure/listedinfo/announcement/c/2009-02-06/600332_20090206_1.pdf
236,2009-03-11,广州药业关于属下企业获得高新技术企业认证的公告,/disclosure/listedinfo/announcement/c/2009-03-11/600332_20090311_1.pdf
237,2009-03-30,广州药业年报摘要,/disclosure/listedinfo/announcement/c/2009-03-30/600332_2008_nzy.pdf
238,2009-03-30,广州药业年报,/disclosure/listedinfo/announcement/c/2009-03-30/600332_2008_n.pdf
239,2009-03-30,广州药业内部审计管理制度,/disclosure/listedinfo/announcement/c/2009-03-30/600332_20090330_6.pdf
240,2009-03-30,广州药业关联方资金往来审核报告,/disclosure/listedinfo/announcement/c/2009-03-30/600332_20090330_5.pdf
241,2009-03-30,广州药业第四届第十四次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-30/600332_20090330_1.pdf
242,2009-03-30,广州药业第四届第八次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-30/600332_20090330_2.pdf
243,2009-03-30,广州药业持续性关联交易公告,/disclosure/listedinfo/announcement/c/2009-03-30/600332_20090330_4.pdf
244,2009-03-30,广州药业持续性关联交易公告,/disclosure/listedinfo/announcement/c/2009-03-30/600332_20090330_3.pdf
245,2009-04-20,广州药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2009-04-20/600332_20090420_1.pdf
246,2009-04-30,广州药业关于召开2008年年度股东大会的通告,/disclosure/listedinfo/announcement/c/2009-04-30/600332_20090430_2.pdf
247,2009-04-30,广州药业董事会审核委员会实施细则,/disclosure/listedinfo/announcement/c/2009-04-30/600332_20090430_3.pdf
248,2009-04-30,广州药业董事、监事及高级管理人员买卖公司股份的管理办法,/disclosure/listedinfo/announcement/c/2009-04-30/600332_20090430_4.pdf
249,2009-04-30,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-30/600332_2009_1.pdf
250,2009-04-30,广州药业第四届第十五次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-30/600332_20090430_1.pdf
251,2009-06-12,广州药业2008年年度股东大会会议资料（修正稿）,/disclosure/listedinfo/announcement/c/2009-06-12/600332_20090612_1a.pdf
252,2009-06-12,广州药业2008年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-06-12/600332_20090612_1.pdf
253,2009-06-22,广州药业2008年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-06-22/600332_20090622_1.pdf
254,2009-06-22,广州药业2008年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-06-22/600332_20090622_2.pdf
255,2009-07-13,广州药业2008年度A股派息实施公告,/disclosure/listedinfo/announcement/c/2009-07-13/600332_20090713_1.pdf
256,2009-08-25,广州药业复牌的提示性公告,/disclosure/listedinfo/announcement/c/2009-08-25/600332_20090825_1.pdf
257,2009-08-31,广州药业第四届第十六次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2009-08-31/600332_20090831_1.pdf
258,2009-08-31,广州药业半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-31/600332_2009_zzy.pdf
259,2009-08-31,广州药业半年报,/disclosure/listedinfo/announcement/c/2009-08-31/600332_2009_z.pdf
260,2009-09-23,广州药业关于控股股东增持公司股份实施情况的公告,/disclosure/listedinfo/announcement/c/2009-09-23/600332_20090923_1.pdf
261,2009-10-30,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-30/600332_2009_3.pdf
262,2009-11-20,广州药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2009-11-20/600332_20091120_1.pdf
263,2009-11-26,广州药业关于股东减持股份的提示性公告,/disclosure/listedinfo/announcement/c/2009-11-26/600332_20091126_1.pdf
264,2009-12-08,广州药业关于中国证监会核准豁免广州医药集团有限公司要约收购公司股份义务的公告,/disclosure/listedinfo/announcement/c/2009-12-08/600332_20091208_1.pdf
265,2010-03-29,广州药业信息披露管理制度,/disclosure/listedinfo/announcement/c/2010-03-29/600332_20100329_4.pdf
266,2010-03-29,广州药业年报摘要,/disclosure/listedinfo/announcement/c/2010-03-29/600332_2009_nzy.pdf
267,2010-03-29,广州药业年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-03-29/600332_20100329_6.pdf
268,2010-03-29,广州药业年报,/disclosure/listedinfo/announcement/c/2010-03-29/600332_2009_n.pdf
269,2010-03-29,广州药业内幕信息知情人登记制度,/disclosure/listedinfo/announcement/c/2010-03-29/600332_20100329_5.pdf
270,2010-03-29,广州药业关联方资金往来的审核报告,/disclosure/listedinfo/announcement/c/2010-03-29/600332_20100329_3.pdf
271,2010-03-29,广州药业第四届第十二次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-29/600332_20100329_2.pdf
272,2010-03-29,广州药业第四届第十八次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-29/600332_20100329_1.pdf
273,2010-04-30,广州药业外部信息使用人管理制度,/disclosure/listedinfo/announcement/c/2010-04-30/600332_20100430_3.pdf
274,2010-04-30,广州药业关于变更香港联席公司秘书,/disclosure/listedinfo/announcement/c/2010-04-30/600332_20100430_2.pdf
275,2010-04-30,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-30/600332_2010_1.pdf
276,2010-04-30,广州药业第四届第十九次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-30/600332_20100430_1.pdf
277,2010-05-12,广州药业关于召开2009年年度股东大会的通告,/disclosure/listedinfo/announcement/c/2010-05-12/600332_20100512_4.pdf
278,2010-05-12,广州药业关于董事辞任的公告,/disclosure/listedinfo/announcement/c/2010-05-12/600332_20100512_3.pdf
279,2010-05-12,广州药业第四届第十四次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-05-12/600332_20100512_2.pdf
280,2010-05-12,广州药业第四届第二十次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-05-12/600332_20100512_1.pdf
281,2010-05-24,广州药业关于董事候选人补充资料的公告,/disclosure/listedinfo/announcement/c/2010-05-24/600332_20100524_2.pdf
282,2010-05-24,广州药业第四届第二十一次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-05-24/600332_20100524_1.pdf
283,2010-06-10,广州药业关于召开2009年年度股东大会的补充通告,/disclosure/listedinfo/announcement/c/2010-06-10/600332_20100610_2.pdf
284,2010-06-10,广州药业第四届第二十二次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-06-10/600332_20100610_1.pdf
285,2010-06-24,广州药业2009年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-06-24/600332_20100624_1.pdf
286,2010-06-29,广州药业第五届第一次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-06-29/600332_20100629_3.pdf
287,2010-06-29,广州药业第五届第一次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-06-29/600332_20100629_2.pdf
288,2010-06-29,广州药业2009年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-06-29/600332_20100629_1.pdf
289,2010-06-29,广州药业2009年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-06-29/600332_20100629_4.pdf
290,2010-07-12,广州药业2009年度A股派息实施公告,/disclosure/listedinfo/announcement/c/2010-07-12/600332_20100712_1.pdf
291,2010-08-30,广州药业监事会议事规则,/disclosure/listedinfo/announcement/c/2010-08-30/600332_20100830_4.pdf
292,2010-08-30,广州药业董事、监事及高级管理人员买卖公司股份的管理办法,/disclosure/listedinfo/announcement/c/2010-08-30/600332_20100830_3.pdf
293,2010-08-30,广州药业第五届第二次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-30/600332_20100830_2.pdf
294,2010-08-30,广州药业第五届第二次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-30/600332_20100830_1.pdf
295,2010-08-30,广州药业半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-30/600332_2010_zzy.pdf
296,2010-08-30,广州药业半年报,/disclosure/listedinfo/announcement/c/2010-08-30/600332_2010_z.pdf
297,2010-09-30,广州药业关于变更香港联席公司秘书的公告,/disclosure/listedinfo/announcement/c/2010-09-30/600332_20100930_2.pdf
298,2010-09-30,广州药业第五届第三次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-09-30/600332_20100930_1.pdf
299,2010-10-29,广州药业第五届第四次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-10-29/600332_20101029_1.pdf
300,2010-10-29,广州药业第五届第三次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-10-29/600332_20101029_2.pdf
301,2010-10-29,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-29/600332_2010_3.pdf
302,2010-10-29,广州药业持续性关联交易公告,/disclosure/listedinfo/announcement/c/2010-10-29/600332_20101029_4.pdf
303,2010-10-29,广州药业持续性关联交易的公告,/disclosure/listedinfo/announcement/c/2010-10-29/600332_20101029_3.pdf
304,2010-11-12,广州药业关于召开临时股东大会的通告,/disclosure/listedinfo/announcement/c/2010-11-12/600332_20101112_1.pdf
305,2010-11-12,广州药业H股通函,/disclosure/listedinfo/announcement/c/2010-11-12/600332_20101112_2.pdf
306,2010-12-17,广州药业现场检查整改报告,/disclosure/listedinfo/announcement/c/2010-12-17/600332_20101217_2.pdf
307,2010-12-17,广州药业第五届第五次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-12-17/600332_20101217_1.pdf
308,2010-12-23,广州药业2010年临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-12-23/600332_20101223_1.pdf
309,2010-12-31,广州药业2010年临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-12-31/600332_20101231_1.pdf
310,2010-12-31,广州药业2010年临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-12-31/600332_20101231_2.pdf
311,2011-01-06,广州药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2011-01-06/600332_20110106_1.pdf
312,2011-03-04,广州药业公告,/disclosure/listedinfo/announcement/c/2011-03-04/600332_20110304_1.pdf
313,2011-03-19,广州药业H股公告,/disclosure/listedinfo/announcement/c/2011-03-19/600332_20110319_1.pdf
314,2011-03-28,广州药业年报摘要,/disclosure/listedinfo/announcement/c/2011-03-28/600332_2010_nzy.pdf
315,2011-03-28,广州药业年报,/disclosure/listedinfo/announcement/c/2011-03-28/600332_2010_n.pdf
316,2011-03-28,广州药业关联方资金往来的审核报告,/disclosure/listedinfo/announcement/c/2011-03-28/600332_20110328_3.pdf
317,2011-03-28,广州药业第五届第四次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-28/600332_20110328_2.pdf
318,2011-03-28,广州药业第五届第六次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-28/600332_20110328_1.pdf
319,2011-03-28,广州药业2010年度社会责任报告,/disclosure/listedinfo/announcement/c/2011-03-28/600332_20110328_5.pdf
320,2011-03-28,广州药业2010年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2011-03-28/600332_20110328_4.pdf
321,2011-04-29,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-29/600332_2011_1.pdf
322,2011-04-29,广州药业第五届第七次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-29/600332_20110429_1.pdf
323,2011-05-04,广州药业关于召开2010年年度股东大会的通告,/disclosure/listedinfo/announcement/c/2011-05-04/600332_20110504_1.pdf
324,2011-05-06,广州药业H股通函,/disclosure/listedinfo/announcement/c/2011-05-06/600332_20110506_1.pdf
325,2011-06-16,广州药业2010年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-06-16/600332_20110616_1.pdf
326,2011-06-22,广州药业董事会秘书工作细则,/disclosure/listedinfo/announcement/c/2011-06-22/600332_20110622_3.pdf
327,2011-06-22,广州药业2010年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-06-22/600332_20110622_1.pdf
328,2011-06-22,广州药业2010年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-06-22/600332_20110622_2.pdf
329,2011-06-29,广州药业公告,/disclosure/listedinfo/announcement/c/2011-06-29/600332_20110629_1.pdf
330,2011-07-01,广州药业关于变更香港联席公司秘书,/disclosure/listedinfo/announcement/c/2011-07-01/600332_20110701_2.pdf
331,2011-07-01,广州药业第五届第九次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2011-07-01/600332_20110701_1.pdf
332,2011-07-11,广州药业2010年度A股派息实施公告,/disclosure/listedinfo/announcement/c/2011-07-11/600332_20110711_1.pdf
333,2011-07-16,广州药业H股公告,/disclosure/listedinfo/announcement/c/2011-07-16/600332_20110716_1.pdf
334,2011-08-27,广州药业半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-27/600332_2011_zzy.pdf
335,2011-08-27,广州药业半年报,/disclosure/listedinfo/announcement/c/2011-08-27/600332_2011_z.pdf
336,2011-10-31,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-31/600332_2011_3.pdf
337,2011-11-08,广州药业重大事项暨停牌公告,/disclosure/listedinfo/announcement/c/2011-11-08/600332_20111108_1.pdf
338,2011-11-14,广州药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2011-11-14/600332_20111114_1.pdf
339,2011-11-21,广州药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2011-11-21/600332_20111121_1.pdf
340,2011-11-28,广州药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2011-11-28/600332_20111128_1.pdf
341,2011-12-05,广州药业内幕信息知情人登记制度,/disclosure/listedinfo/announcement/c/2011-12-05/600332_20111205_3.pdf
342,2011-12-05,广州药业关于延长停牌时间的公告,/disclosure/listedinfo/announcement/c/2011-12-05/600332_20111205_2.pdf
343,2011-12-05,广州药业第五届董事会书面决议公告,/disclosure/listedinfo/announcement/c/2011-12-05/600332_20111205_1.pdf
344,2011-12-12,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2011-12-12/600332_20111212_1.pdf
345,2011-12-19,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2011-12-19/600332_20111219_1.pdf
346,2011-12-26,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2011-12-26/600332_20111226_1.pdf
347,2012-01-04,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-01-04/600332_20120104_1.pdf
348,2012-01-09,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-01-09/600332_20120109_1.pdf
349,2012-01-16,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-01-16/600332_20120116_1.pdf
350,2012-01-30,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-01-30/600332_20120130_1.pdf
351,2012-01-30,广州药业财务总监工作细则,/disclosure/listedinfo/announcement/c/2012-01-30/600332_20120130_2.pdf
352,2012-02-06,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-02-06/600332_20120206_1.pdf
353,2012-02-13,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-02-13/600332_20120213_1.pdf
354,2012-02-17,广州药业年报摘要,/disclosure/listedinfo/announcement/c/2012-02-17/600332_2011_nzy.pdf
355,2012-02-17,广州药业年报,/disclosure/listedinfo/announcement/c/2012-02-17/600332_2011_n.pdf
356,2012-02-17,广州药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2012-02-17/600332_20120217_7.pdf
357,2012-02-17,广州药业控股股东及其他关联方占用资金情况专项说明,/disclosure/listedinfo/announcement/c/2012-02-17/600332_20120217_4.pdf
358,2012-02-17,广州药业关于召开2011年年度股东大会的通告,/disclosure/listedinfo/announcement/c/2012-02-17/600332_20120217_3.pdf
359,2012-02-17,广州药业独立董事2011年度述职报告,/disclosure/listedinfo/announcement/c/2012-02-17/600332_20120217_5.pdf
360,2012-02-17,广州药业第五届第十二次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2012-02-17/600332_20120217_1.pdf
361,2012-02-17,广州药业第五届第八次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2012-02-17/600332_20120217_2.pdf
362,2012-02-17,广州药业2011年度社会责任报告,/disclosure/listedinfo/announcement/c/2012-02-17/600332_20120217_8.pdf
363,2012-02-17,广州药业2011年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2012-02-17/600332_20120217_6.pdf
364,2012-02-20,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-02-20/600332_20120220_1.pdf
365,2012-02-27,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-02-27/600332_20120227_1.pdf
366,2012-02-27,广州药业H股公告,/disclosure/listedinfo/announcement/c/2012-02-27/600332_20120227_2.pdf
367,2012-03-05,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-03-05/600332_20120305_1.pdf
368,2012-03-12,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-03-12/600332_20120312_1.pdf
369,2012-03-19,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-03-19/600332_20120319_1.pdf
370,2012-03-26,广州药业关于重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2012-03-26/600332_20120326_1.pdf
371,2012-03-28,广州药业换股吸收合并广州白云山制药股份有限公司、发行股份购买资产暨关联交易预案,/disclosure/listedinfo/announcement/c/2012-03-28/600332_20120328_4.pdf
372,2012-03-28,广州药业董事会提名与薪酬委员会实施细则,/disclosure/listedinfo/announcement/c/2012-03-28/600332_20120328_5.pdf
373,2012-03-28,广州药业董事会审核委员会实施细则,/disclosure/listedinfo/announcement/c/2012-03-28/600332_20120328_6.pdf
374,2012-03-28,广州药业第五届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-28/600332_20120328_3.pdf
375,2012-03-28,广州药业第五届董事会书面决议公告,/disclosure/listedinfo/announcement/c/2012-03-28/600332_20120328_1.pdf
376,2012-03-28,广州药业第五届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-28/600332_20120328_2.pdf
377,2012-03-31,广州药业2011年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-03-31/600332_20120331_1.pdf
378,2012-04-13,广州药业2011年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-04-13/600332_20120413_1.pdf
379,2012-04-13,广州药业2011年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-04-13/600332_20120413_2.pdf
380,2012-04-27,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-27/600332_2012_1.pdf
381,2012-04-27,广州药业第五届第十四次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-27/600332_20120427_1.pdf
382,2012-05-14,广州药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2012-05-14/600332_20120514_2.pdf
383,2012-05-14,广州药业2011年度A股派息实施公告,/disclosure/listedinfo/announcement/c/2012-05-14/600332_20120514_1.pdf
384,2012-05-15,广州药业董事会秘书工作细则,/disclosure/listedinfo/announcement/c/2012-05-15/600332_20120515_4.pdf
385,2012-05-15,广州药业第五届第十一次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-15/600332_20120515_2.pdf
386,2012-05-15,广州药业第五届第十五次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-15/600332_20120515_1.pdf
387,2012-05-15,广州药业持续性关联交易公告,/disclosure/listedinfo/announcement/c/2012-05-15/600332_20120515_3.pdf
388,2012-05-28,广州药业第五届第十六次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-28/600332_20120528_1.pdf
389,2012-05-28,广州药业第五届第十二次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2012-05-28/600332_20120528_2.pdf
390,2012-05-28,广州药业持续性关联交易公告,/disclosure/listedinfo/announcement/c/2012-05-28/600332_20120528_3.pdf
391,2012-06-05,广州药业公告,/disclosure/listedinfo/announcement/c/2012-06-05/600332_20120605_1.pdf
392,2012-06-19,广州药业换股吸收合并广州白云山制药股份有限公司、发行股份购买资产暨关联交易报告书（草案）摘要,/disclosure/listedinfo/announcement/c/2012-06-19/600332_20120619_7.pdf
393,2012-06-19,广州药业换股吸收合并广州白云山制药股份有限公司、发行股份购买资产暨关联交易报告书（草案）,/disclosure/listedinfo/announcement/c/2012-06-19/600332_20120619_6.pdf
394,2012-06-19,广州药业关于董事辞任的公告,/disclosure/listedinfo/announcement/c/2012-06-19/600332_20120619_2.pdf
395,2012-06-19,广州药业第五届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2012-06-19/600332_20120619_4.pdf
396,2012-06-19,广州药业第五届董事会会议书面决议公告,/disclosure/listedinfo/announcement/c/2012-06-19/600332_20120619_1.pdf
397,2012-06-19,广州药业第五届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2012-06-19/600332_20120619_3.pdf
398,2012-06-19,广州药业H股公告,/disclosure/listedinfo/announcement/c/2012-06-19/600332_20120619_5.pdf
399,2012-06-29,广州药业公告,/disclosure/listedinfo/announcement/c/2012-06-29/600332_20120629_1.pdf
400,2012-07-16,广州药业公告,/disclosure/listedinfo/announcement/c/2012-07-16/600332_20120716_1.pdf
401,2012-07-17,广州药业第五届董事会书面决议公告,/disclosure/listedinfo/announcement/c/2012-07-17/600332_20120717_1.pdf
402,2012-07-24,广州药业公告,/disclosure/listedinfo/announcement/c/2012-07-24/600332_20120724_1.pdf
403,2012-08-03,广州药业关于召开2012年第一次内资股股东之类别股东大会通告,/disclosure/listedinfo/announcement/c/2012-08-03/600332_20120803_1.pdf
404,2012-08-03,广州药业关于召开2012年第一次临时股东大会通告,/disclosure/listedinfo/announcement/c/2012-08-03/600332_20120803_3.pdf
405,2012-08-03,广州药业关于召开2012年第一次境外上市外资股股东之类别股东大会通告,/disclosure/listedinfo/announcement/c/2012-08-03/600332_20120803_2.pdf
406,2012-08-04,广州药业关于召开2012年第一次内资股股东之类别股东大会补充通告,/disclosure/listedinfo/announcement/c/2012-08-04/600332_20120804_1.pdf
407,2012-08-07,广州药业公告,/disclosure/listedinfo/announcement/c/2012-08-07/600332_20120807_1.pdf
408,2012-08-15,广州药业关于诉讼的公告,/disclosure/listedinfo/announcement/c/2012-08-15/600332_20120815_1.pdf
409,2012-08-20,广州药业关于召开2012年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2012-08-20/600332_20120820_1.pdf
410,2012-08-27,广州药业第五届第十八次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-27/600332_20120827_1.pdf
411,2012-08-27,广州药业半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-27/600332_2012_zzy.pdf
412,2012-08-27,广州药业半年报,/disclosure/listedinfo/announcement/c/2012-08-27/600332_2012_z.pdf
413,2012-08-27,广州药业H股公告,/disclosure/listedinfo/announcement/c/2012-08-27/600332_20120827_2.pdf
414,2012-09-01,广州药业关于召开2012年第一次临时股东大会的第二次提示性公告,/disclosure/listedinfo/announcement/c/2012-09-01/600332_20120901_1.pdf
415,2012-09-01,广州药业关于召开2012年第一次境外上市外资股股东之类别股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2012-09-01/600332_20120901_2.pdf
416,2012-09-04,广州药业H股通函,/disclosure/listedinfo/announcement/c/2012-09-04/600332_20120904_1.pdf
417,2012-09-13,广州药业2012年第一次临时股东大会暨类别股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-09-13/600332_20120913_1.pdf
418,2012-09-18,广州药业关于确定现金选择权提供方的公告,/disclosure/listedinfo/announcement/c/2012-09-18/600332_20120918_1.pdf
419,2012-09-20,广州药业关于重组方案获商务部反垄断局和国资委批准及拟购买资产评估结果获国资委核准/备案的公告,/disclosure/listedinfo/announcement/c/2012-09-20/600332_20120920_5.pdf
420,2012-09-20,广州药业关于换股吸收合并广州白云山制药股份有限公司的债权人公告,/disclosure/listedinfo/announcement/c/2012-09-20/600332_20120920_4.pdf
421,2012-09-20,广州药业公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-09-20/600332_20120920_g.pdf
422,2012-09-20,广州药业H股公告,/disclosure/listedinfo/announcement/c/2012-09-20/600332_20120920_6.pdf
423,2012-09-20,广州药业2012年第一次内资股股东之类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-09-20/600332_20120920_3.pdf
424,2012-09-20,广州药业2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-09-20/600332_20120920_1.pdf
425,2012-09-20,广州药业2012年第一次临时股东大会和2012年第一次内资股、外资股类别股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-09-20/600332_20120920_7.pdf
426,2012-09-20,广州药业2012年第一次境外上市外资股股东之类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-09-20/600332_20120920_2.pdf
427,2012-10-10,广州药业关于换股吸收合并广州白云山制药股份有限公司的债权人第二次提示性公告,/disclosure/listedinfo/announcement/c/2012-10-10/600332_20121010_1.pdf
428,2012-10-17,广州药业关于重大资产重组进展的公告,/disclosure/listedinfo/announcement/c/2012-10-17/600332_20121017_1.pdf
429,2012-10-19,广州药业关于换股吸收合并广州白云山制药股份有限公司的债权人第三次提示性公告,/disclosure/listedinfo/announcement/c/2012-10-19/600332_20121019_1.pdf
430,2012-10-30,广州药业关于公司股东、关联方以及公司尚未履行完毕的承诺情况的公告,/disclosure/listedinfo/announcement/c/2012-10-30/600332_20121030_1.pdf
431,2012-10-30,广州药业第五届第十九次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2012-10-30/600332_20121030_2.pdf
432,2012-10-30,广州药业第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-30/600332_2012_3.pdf
433,2012-11-09,广州药业关于变更H股异议股东收购请求权提供方的公告,/disclosure/listedinfo/announcement/c/2012-11-09/600332_20121109_1.pdf
434,2012-11-23,广州药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2012-11-23/600332_20121123_1.pdf
435,2012-12-01,广州药业关于重大资产重组事宜获得中国证监会并购重组审核委员会审核通过暨公司股票复牌的公告,/disclosure/listedinfo/announcement/c/2012-12-01/600332_20121201_1.pdf
436,2012-12-22,广州药业换股吸收合并广州白云山制药股份有限公司、发行股份购买资产暨关联交易之独立财务顾问专项核查意见书,/disclosure/listedinfo/announcement/c/2012-12-22/600332_20121222_4.pdf
437,2012-12-22,广州药业换股吸收合并广州白云山制药股份有限公司、发行股份购买资产暨关联交易之补充法律意见书（一）,/disclosure/listedinfo/announcement/c/2012-12-22/600332_20121222_5.pdf
438,2012-12-22,广州药业换股吸收合并广州白云山制药股份有限公司、发行股份购买资产暨关联交易报告书,/disclosure/listedinfo/announcement/c/2012-12-22/600332_20121222_3.pdf
439,2012-12-22,广州药业关于重大资产重组事宜获得中国证券监督管理委员会核准的公告,/disclosure/listedinfo/announcement/c/2012-12-22/600332_20121222_1.pdf
440,2012-12-22,广州药业关于广州药业股份有限公司换股吸收合并广州白云山制药股份有限公司、发行股份购买资产暨关联交易报告书的修订说明,/disclosure/listedinfo/announcement/c/2012-12-22/600332_20121222_2.pdf
441,2013-01-17,广州药业第五届第二十次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-01-16/600332_20130117_1.pdf
442,2013-03-01,广州药业年报摘要,/disclosure/listedinfo/announcement/c/2013-02-28/600332_2012_nzy.pdf
443,2013-03-01,广州药业年报,/disclosure/listedinfo/announcement/c/2013-02-28/600332_2012_n.pdf
444,2013-03-01,广州药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-02-28/600332_20130301_6.pdf
445,2013-03-01,广州药业控股股东及其他关联方占用资金情况专项说明,/disclosure/listedinfo/announcement/c/2013-02-28/600332_20130301_10.pdf
446,2013-03-01,广州药业独立董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-02-28/600332_20130301_8.pdf
447,2013-03-01,广州药业第五届第十六次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-02-28/600332_20130301_1.pdf
448,2013-03-01,广州药业第五届第二十一次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-02-28/600332_20130301_2.pdf
449,2013-03-01,广州药业2012年度社会责任报告,/disclosure/listedinfo/announcement/c/2013-02-28/600332_20130301_4.pdf
450,2013-03-01,广州药业2012年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2013-02-28/600332_20130301_5.pdf
451,2013-03-01,广州药业2012年度财务报表及审计报告,/disclosure/listedinfo/announcement/c/2013-02-28/600332_20130301_9.pdf
452,2013-03-07,广州药业关于换股吸收合并广州白云山制药股份有限公司事宜的提示性公告,/disclosure/listedinfo/announcement/c/2013-03-06/600332_20130307_2.pdf
453,2013-03-07,广州药业关于换股吸收合并广州白云山制药股份有限公司A股异议股东收购请求权实施公告,/disclosure/listedinfo/announcement/c/2013-03-06/600332_20130307_1.pdf
454,2013-03-13,广州药业关于换股吸收合并广州白云山制药股份有限公司A股异议股东收购请求权实施第一次提示性公告,/disclosure/listedinfo/announcement/c/2013-03-12/600332_20130313_1.pdf
455,2013-03-18,广州药业关于换股吸收合并广州白云山制药股份有限公司A股异议股东收购请求权实施第二次提示性公告,/disclosure/listedinfo/announcement/c/2013-03-17/600332_20130318_2.pdf
456,2013-03-18,广州药业关于A股股票停牌的公告,/disclosure/listedinfo/announcement/c/2013-03-17/600332_20130318_1.pdf
457,2013-03-19,广州药业关于换股吸收合并广州白云山制药股份有限公司A股异议股东收购请求权申报结果公告,/disclosure/listedinfo/announcement/c/2013-03-18/600332_20130319_1.pdf
458,2013-03-19,广州药业H股公告,/disclosure/listedinfo/announcement/c/2013-03-18/600332_20130319_2.pdf
459,2013-03-26,广州药业澄清公告,/disclosure/listedinfo/announcement/c/2013-03-25/600332_20130326_1.pdf
460,2013-03-29,广州药业关于相关媒体报道的说明公告,/disclosure/listedinfo/announcement/c/2013-03-28/600332_20130329_1.pdf
461,2013-04-11,广州药业关于相关媒体报道的进一步公告,/disclosure/listedinfo/announcement/c/2013-04-10/600332_20130411_2.pdf
462,2013-04-11,广州药业关于广州白云山制药股份有限公司投资者做好跨市场转登记相关工作的提示性公告,/disclosure/listedinfo/announcement/c/2013-04-10/600332_20130411_1.pdf
463,2013-04-26,广州药业关于换股吸收合并广州白云山制药股份有限公司有关问题的回答,/disclosure/listedinfo/announcement/c/2013-04-25/600332_20130426_2.pdf
464,2013-04-26,广州药业关于换股吸合并广州白云山制药股份有限公司的换股实施公告,/disclosure/listedinfo/announcement/c/2013-04-25/600332_20130426_3.pdf
465,2013-04-26,广州药业关于广州白云山制药股份有限公司投资者做好跨市场转登记相关工作的公告,/disclosure/listedinfo/announcement/c/2013-04-25/600332_20130426_1.pdf
466,2013-04-27,广州药业第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-26/600332_2013_1.pdf
467,2013-04-27,广州药业第五届第十七次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-27/600332_20130427_6.pdf
468,2013-04-27,广州药业第五届第二十二次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-27/600332_20130427_5.pdf
469,2013-04-27,广州药业持续性关联交易公告,/disclosure/listedinfo/announcement/c/2013-04-27/600332_20130427_7.pdf
470,2013-04-27,广州药业H股公告,/disclosure/listedinfo/announcement/c/2013-04-27/600332_20130427_2.pdf
471,2013-05-08,广州药业关于广州白云山制药股份有限公司投资者做好跨市场转登记相关工作的提示性公告,/disclosure/listedinfo/announcement/c/2013-05-07/600332_20130508_1.pdf
472,2013-05-09,广州药业关于召开2012年年度股东大会的通告,/disclosure/listedinfo/announcement/c/2013-05-08/600332_20130509_2.pdf
473,2013-05-09,广州药业H股公告,/disclosure/listedinfo/announcement/c/2013-05-08/600332_20130509_1.pdf
474,2013-05-18,广州药业关于未完成初始登记的原广州白云山制药股份有限公司投资者做好补登记相关工作的公告,/disclosure/listedinfo/announcement/c/2013-05-17/600332_20130518_2.pdf
475,2013-05-18,广州药业关于举行重大资产重组说明会的预告公告,/disclosure/listedinfo/announcement/c/2013-05-17/600332_20130518_3.pdf
476,2013-05-18,广州药业关于换股吸收合并广州白云山制药股份有限公司完成结果、股份变动暨新增股份上市公告,/disclosure/listedinfo/announcement/c/2013-05-17/600332_20130518_1.pdf
477,2013-05-29,广州药业关于召开2012年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2013-05-28/600332_20130529_1.pdf
478,2013-06-14,广州药业关于相关土地进入批前公示的公告,/disclosure/listedinfo/announcement/c/2013-06-13/600332_20130614_1.pdf
479,2013-06-20,广州药业2012年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-06-19/600332_20130620_1.pdf
480,2013-06-27,广州药业2012年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-06-26/600332_20130627_1.pdf
481,2013-06-27,广州药业2012年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-06-26/600332_20130627_2.pdf
482,2013-07-03,广州药业关于发行股份购买资产相关资产交割完成的公告,/disclosure/listedinfo/announcement/c/2013-07-02/600332_20130703_1.pdf
483,2013-07-03,广州药业发行股份购买资产暨关联交易实施情况之专项核查意见,/disclosure/listedinfo/announcement/c/2013-07-02/600332_20130703_2.pdf
484,2013-07-03,广州药业发行股份购买资产暨关联交易实施情况之法律意见书,/disclosure/listedinfo/announcement/c/2013-07-02/600332_20130703_3.pdf
485,2013-07-09,广州药业关于非公开发行股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2013-07-08/600332_20130709_1.pdf
486,2013-07-17,广州药业公司章程（2013修订）,/disclosure/listedinfo/announcement/c/2013-07-16/600332_20130717_1.pdf
487,2013-07-17,广州药业第五届第二十三次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-07-16/600332_20130717_2.pdf
488,2013-08-09,广州药业董事长辞任公告,/disclosure/listedinfo/announcement/c/2013-08-08/600332_20130809_2.pdf
489,2013-08-09,广州药业第五届第二十四次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-08/600332_20130809_1.pdf
490,2013-08-26,广州药业关于公司名称、证券简称及其他事项变更的公告,/disclosure/listedinfo/announcement/c/2013-08-25/600332_20130826_2.pdf
491,2013-08-26,广州药业第五届第二十五次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-25/600332_20130826_1.pdf
492,2013-08-27,广州药业换股吸收合并广州白云山制药股份有限公司、发行股份购买资产暨关联交易实施情况之法律意见书,/disclosure/listedinfo/announcement/c/2013-08-26/600332_20130827_3.pdf
493,2013-08-27,广州药业换股吸收合并、发行股份购买资产暨关联交易之实施情况报告书,/disclosure/listedinfo/announcement/c/2013-08-26/600332_20130827_1.pdf
494,2013-08-27,广州药业换股吸收合并、发行股份购买资产暨关联交易实施情况之专项核查意见,/disclosure/listedinfo/announcement/c/2013-08-26/600332_20130827_2.pdf
495,2013-08-31,白云山第五届第二十六次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-30/600332_20130831_3.pdf
496,2013-08-31,白云山半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-30/600332_2013_zzy.pdf
497,2013-08-31,白云山半年报,/disclosure/listedinfo/announcement/c/2013-08-30/600332_2013_z.pdf
498,2013-09-27,白云山关于变更公司网址的公告,/disclosure/listedinfo/announcement/c/2013-09-26/600332_20130927_2.pdf
499,2013-09-27,白云山董事会提名与薪酬委员会实施细则,/disclosure/listedinfo/announcement/c/2013-09-26/600332_20130927_3.pdf
500,2013-09-27,白云山第五届第二十七次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-09-26/600332_20130927_1.pdf
501,2013-09-27,白云山H股公告,/disclosure/listedinfo/announcement/c/2013-09-26/600332_20130927_4.pdf
502,2013-10-24,白云山公告,/disclosure/listedinfo/announcement/c/2013-10-23/600332_20131024_1.pdf
503,2013-10-31,白云山关于修订公司章程的公告,/disclosure/listedinfo/announcement/c/2013-10-30/600332_20131031_5.pdf
504,2013-10-31,白云山股东大会议事规则,/disclosure/listedinfo/announcement/c/2013-10-30/600332_20131031_7.pdf
505,2013-10-31,白云山独立董事制度,/disclosure/listedinfo/announcement/c/2013-10-30/600332_20131031_9.pdf
506,2013-10-31,白云山董事会议事规则,/disclosure/listedinfo/announcement/c/2013-10-30/600332_20131031_8.pdf
507,2013-10-31,白云山第五届第十九次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-10-30/600332_20131031_3.pdf
508,2013-10-31,白云山第五届第二十八次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-10-30/600332_20131031_2.pdf
509,2013-10-31,白云山第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-30/600332_2013_3.pdf
510,2013-10-31,白云山持续性关联交易公告,/disclosure/listedinfo/announcement/c/2013-10-30/600332_20131031_4.pdf
511,2013-11-07,白云山关于召开2013年临时股东大会通告,/disclosure/listedinfo/announcement/c/2013-11-06/600332_20131107_1.pdf
512,2013-11-09,白云山H股通函,/disclosure/listedinfo/announcement/c/2013-11-08/600332_20131109_1.pdf
513,2013-11-23,白云山公告,/disclosure/listedinfo/announcement/c/2013-11-22/600332_20131123_1.pdf
514,2013-11-27,白云山关于变更公司联系方式的公告,/disclosure/listedinfo/announcement/c/2013-11-26/600332_20131127_2.pdf
515,2013-11-27,白云山第五届第二十九次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-11-26/600332_20131127_1.pdf
516,2013-11-29,白云山公告,/disclosure/listedinfo/announcement/c/2013-11-28/600332_20131129_1.pdf
517,2013-12-04,白云山公告,/disclosure/listedinfo/announcement/c/2013-12-03/600332_20131204_1.pdf
518,2013-12-06,白云山公告,/disclosure/listedinfo/announcement/c/2013-12-05/600332_20131206_1.pdf
519,2013-12-07,白云山为全资子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_4.pdf
520,2013-12-07,白云山关于召开2014年第一次临时股东大会的通告,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_5.pdf
521,2013-12-07,白云山关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_3.pdf
522,2013-12-07,白云山独立非执行董事提名人声明,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_6.pdf
523,2013-12-07,白云山独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_9.pdf
524,2013-12-07,白云山独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_8.pdf
525,2013-12-07,白云山独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_7.pdf
526,2013-12-07,白云山董事会议事规则,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_10.pdf
527,2013-12-07,白云山第五届第三十次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_1.pdf
528,2013-12-07,白云山第五届第二十次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-12-06/600332_20131207_2.pdf
529,2013-12-09,白云山股票停牌公告,/disclosure/listedinfo/announcement/c/2013-12-08/600332_20131209_1.pdf
530,2013-12-11,白云山H股通函,/disclosure/listedinfo/announcement/c/2013-12-10/600332_20131211_1.pdf
531,2013-12-14,白云山关于治疗性双质粒HBV DNA疫苗IIb期临床研究工作初步结果的公告,/disclosure/listedinfo/announcement/c/2013-12-13/600332_20131214_1.pdf
532,2013-12-14,白云山关于公司股票复牌公告,/disclosure/listedinfo/announcement/c/2013-12-13/600332_20131214_2.pdf
533,2013-12-14,白云山：治疗性双质粒HBV DNA疫苗治疗HBeAg阳性的慢性乙型肝炎的疗效及安全性的随机、双盲、对照、多中心的Ⅱb期临床试验结果讨论,/disclosure/listedinfo/announcement/c/2013-12-13/600332_20131214_3.pdf
534,2013-12-21,白云山公告,/disclosure/listedinfo/announcement/c/2013-12-20/600332_20131221_2.pdf
535,2013-12-21,白云山2013年临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-12-20/600332_20131221_1.pdf
536,2013-12-25,白云山公告,/disclosure/listedinfo/announcement/c/2013-12-24/600332_20131225_1.pdf
537,2013-12-27,白云山第五届第三十一次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-12-26/600332_20131227_1.pdf
538,2013-12-31,白云山2013年临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-12-30/600332_20131231_1.pdf
539,2013-12-31,白云山2013年临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2013-12-30/600332_20131231_2.pdf
540,2014-01-17,白云山A股派发特别股息实施公告,/disclosure/listedinfo/announcement/c/2014-01-16/600332_20140117_1.pdf
541,2014-01-22,白云山2014年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-01-21/600332_20140122_1.pdf
542,2014-01-29,白云山关于变更独立财务顾问项目主办人公告,/disclosure/listedinfo/announcement/c/2014-01-28/600332_20140129_4.pdf
543,2014-01-29,白云山公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-01-28/600332_20140129_7.pdf
544,2014-01-29,白云山第六届第一次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-01-28/600332_20140129_3.pdf
545,2014-01-29,白云山第六届第一次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-01-28/600332_20140129_2.pdf
546,2014-01-29,白云山H股公告,/disclosure/listedinfo/announcement/c/2014-01-28/600332_20140129_6.pdf
547,2014-01-29,白云山2014年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-01-28/600332_20140129_1.pdf
548,2014-01-29,白云山2014年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2014-01-28/600332_20140129_5.pdf
549,2014-01-30,白云山关于变更公司联系方式的公告,/disclosure/listedinfo/announcement/c/2014-01-29/600332_20140130_1.pdf
550,2014-02-15,白云山关于公司股东、关联方以及公司尚未履行完毕的承诺情况的公告,/disclosure/listedinfo/announcement/c/2014-02-14/600332_20140215_1.pdf
551,2014-03-05,白云山股票停牌公告,/disclosure/listedinfo/announcement/c/2014-03-04/600332_20140305_1.pdf
552,2014-03-06,白云山股票复牌公告,/disclosure/listedinfo/announcement/c/2014-03-05/600332_20140306_2.pdf
553,2014-03-06,白云山公告,/disclosure/listedinfo/announcement/c/2014-03-05/600332_20140306_1.pdf
554,2014-03-14,白云山关于治疗性双质粒HBV DNA疫苗IIb期临床试验总结会得出的试验结果的公告,/disclosure/listedinfo/announcement/c/2014-03-13/600332_20140314_1.pdf
555,2014-03-18,白云山向下属部分企业提供担保的公告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_6.pdf
556,2014-03-18,白云山属下广州白云山拜迪生物医药有限公司按持股比例向广州诺诚生物制品股份有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_7.pdf
557,2014-03-18,白云山日常关联交易公告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_4.pdf
558,2014-03-18,白云山年报摘要,/disclosure/listedinfo/announcement/c/2014-03-17/600332_2013_nzy.pdf
559,2014-03-18,白云山年报,/disclosure/listedinfo/announcement/c/2014-03-17/600332_2013_n.pdf
560,2014-03-18,白云山内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_15.pdf
561,2014-03-18,白云山关联交易公告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_8.pdf
562,2014-03-18,白云山关联交易公告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_5.pdf
563,2014-03-18,白云山独立董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_12.pdf
564,2014-03-18,白云山第六届第二次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_3.pdf
565,2014-03-18,白云山第六届第二次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_2.pdf
566,2014-03-18,白云山：关于对广州白云山医药集团股份有限公司控股股东及其他关联方占用资金情况的专项审计说明,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_11.pdf
567,2014-03-18,白云山2013年度社会责任报告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_14.pdf
568,2014-03-18,白云山2013年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_13.pdf
569,2014-03-18,白云山2013年度财务报表及审计报告,/disclosure/listedinfo/announcement/c/2014-03-17/600332_20140318_10.pdf
570,2014-03-20,白云山2013年度非经营性资金占用及其他关联资金往来情况汇总表,/disclosure/listedinfo/announcement/c/2014-03-19/600332_20140320_1.pdf
571,2014-04-05,白云山关于广州医药集团有限公司拟执行《净收益补偿协议》的公告,/disclosure/listedinfo/announcement/c/2014-04-04/600332_20140405_1.pdf
572,2014-04-05,白云山：国泰君安证券股份有限公司关于广州白云山医药集团股份有限公司重大资产重组实施情况之独立财务顾问持续督导意见,/disclosure/listedinfo/announcement/c/2014-04-04/600332_20140405_2.pdf
573,2014-04-05,白云山2013年盈利预测实现情况-商标专项审计报告,/disclosure/listedinfo/announcement/c/2014-04-04/600332_20140405_3.pdf
574,2014-04-05,白云山2013年盈利预测实现情况-经扩大重组框架专项审计报告,/disclosure/listedinfo/announcement/c/2014-04-04/600332_20140405_6.pdf
575,2014-04-05,白云山2013年盈利预测实现情况-购买资产专项审计报告,/disclosure/listedinfo/announcement/c/2014-04-04/600332_20140405_4.pdf
576,2014-04-05,白云山2013年盈利预测实现情况-房产专项审计报告,/disclosure/listedinfo/announcement/c/2014-04-04/600332_20140405_5.pdf
577,2014-04-17,白云山第六届董事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-16/600332_20140417_1.pdf
578,2014-04-24,白云山关于控股股东规范相关承诺事项的公告,/disclosure/listedinfo/announcement/c/2014-04-23/600332_20140424_1.pdf
579,2014-04-29,白云山投资者投诉处理工作制度,/disclosure/listedinfo/announcement/c/2014-04-28/600332_20140429_6.pdf
580,2014-04-29,白云山关于召开2013年年度股东大会的通告,/disclosure/listedinfo/announcement/c/2014-04-28/600332_20140429_4.pdf
581,2014-04-29,白云山关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2014-04-28/600332_20140429_3.pdf
582,2014-04-29,白云山第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-28/600332_2014_1.pdf
583,2014-04-29,白云山第六届第三次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-28/600332_20140429_2.pdf
584,2014-04-30,白云山未来三年（2014-2016年）股东回报规划,/disclosure/listedinfo/announcement/c/2014-04-29/600332_20140430_1.pdf
585,2014-05-08,白云山关于“王老吉”商标的相关公告,/disclosure/listedinfo/announcement/c/2014-05-07/600332_20140508_1.pdf
586,2014-05-09,白云山公告,/disclosure/listedinfo/announcement/c/2014-05-08/600332_20140509_2.pdf
587,2014-05-09,白云山H股通函,/disclosure/listedinfo/announcement/c/2014-05-08/600332_20140509_1.pdf
588,2014-05-30,白云山关于召开2013年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2014-05-29/600332_20140530_1.pdf
589,2014-06-05,白云山公告,/disclosure/listedinfo/announcement/c/2014-06-04/600332_20140605_1.pdf
590,2014-06-19,白云山2013年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-06-18/600332_20140619_1.pdf
591,2014-06-25,白云山公告,/disclosure/listedinfo/announcement/c/2014-06-24/600332_20140625_1.pdf
592,2014-06-26,白云山关于控股股东规范相关承诺事项的公告,/disclosure/listedinfo/announcement/c/2014-06-25/600332_20140626_1.pdf
593,2014-06-26,白云山关于公司股东、关联方以及公司尚未履行完毕的承诺情况的公告,/disclosure/listedinfo/announcement/c/2014-06-25/600332_20140626_2.pdf
594,2014-06-27,白云山公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-06-26/600332_20140627_4.pdf
595,2014-06-27,白云山公告,/disclosure/listedinfo/announcement/c/2014-06-26/600332_20140627_2.pdf
596,2014-06-27,白云山2013年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-06-26/600332_20140627_1.pdf
597,2014-06-27,白云山2013年年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2014-06-26/600332_20140627_3.pdf
598,2014-07-08,白云山通知债权人公告,/disclosure/listedinfo/announcement/c/2014-07-07/600332_20140708_1.pdf
599,2014-07-09,白云山澄清公告,/disclosure/listedinfo/announcement/c/2014-07-08/600332_20140709_1.pdf
600,2014-07-12,白云山公告,/disclosure/listedinfo/announcement/c/2014-07-11/600332_20140712_1.pdf
601,2014-07-15,白云山通知债权人第二次提示性公告,/disclosure/listedinfo/announcement/c/2014-07-14/600332_20140715_1.pdf
602,2014-07-18,白云山公告,/disclosure/listedinfo/announcement/c/2014-07-17/600332_20140718_1.pdf
603,2014-07-22,白云山通知债权人第三次提示性公告,/disclosure/listedinfo/announcement/c/2014-07-21/600332_20140722_1.pdf
604,2014-07-24,白云山2013年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2014-07-23/600332_20140724_2.pdf
605,2014-07-29,白云山关于相关土地规划调整进入批前公示的公告,/disclosure/listedinfo/announcement/c/2014-07-28/600332_20140729_1.pdf
606,2014-08-01,白云山澄清公告,/disclosure/listedinfo/announcement/c/2014-07-31/600332_20140801_1.pdf
607,2014-08-05,白云山公告,/disclosure/listedinfo/announcement/c/2014-08-04/600332_20140805_2.pdf
608,2014-08-05,白云山公告,/disclosure/listedinfo/announcement/c/2014-08-04/600332_20140805_1.pdf
609,2014-08-06,白云山公告,/disclosure/listedinfo/announcement/c/2014-08-05/600332_20140806_1.pdf
610,2014-08-23,白云山公告,/disclosure/listedinfo/announcement/c/2014-08-22/600332_20140823_1.pdf
611,2014-08-30,白云山投资者关系管理制度,/disclosure/listedinfo/announcement/c/2014-08-29/600332_20140830_4.pdf
612,2014-08-30,白云山第六届第四次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-29/600332_20140830_2.pdf
613,2014-08-30,白云山半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-29/600332_2014_zzy.pdf
614,2014-08-30,白云山半年报,/disclosure/listedinfo/announcement/c/2014-08-29/600332_2014_z.pdf
615,2014-09-03,白云山关于取得“金戈”药品生产批件的公告,/disclosure/listedinfo/announcement/c/2014-09-02/600332_20140903_1.pdf
616,2014-09-20,白云山第六届第五次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-09-19/600332_20140920_1.pdf
617,2014-09-25,白云山涉及仲裁公告,/disclosure/listedinfo/announcement/c/2014-09-24/600332_20140925_1.pdf
618,2014-10-09,白云山公告,/disclosure/listedinfo/announcement/c/2014-10-08/600332_20141009_1.pdf
619,2014-10-30,白云山独立董事关于执行新会计准则会计政策变更的意见函,/disclosure/listedinfo/announcement/c/2014-10-29/600332_20141030_5.pdf
620,2014-10-30,白云山第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-29/600332_2014_3.pdf
621,2014-10-30,白云山第六届第五次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-29/600332_20141030_3.pdf
622,2014-10-30,白云山第六届第六次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-29/600332_20141030_2.pdf
623,2014-11-11,白云山公告,/disclosure/listedinfo/announcement/c/2014-11-10/600332_20141111_1.pdf
624,2014-11-19,白云山公告,/disclosure/listedinfo/announcement/c/2014-11-18/600332_20141119_1.pdf
625,2014-12-04,白云山公告,/disclosure/listedinfo/announcement/c/2014-12-03/600332_20141204_2.pdf
626,2014-12-04,白云山公告,/disclosure/listedinfo/announcement/c/2014-12-03/600332_20141204_1.pdf
627,2014-12-05,白云山公告,/disclosure/listedinfo/announcement/c/2014-12-04/600332_20141205_1.pdf
628,2014-12-11,白云山重大事项继续停牌公告,/disclosure/listedinfo/announcement/c/2014-12-10/600332_20141211_1.pdf
629,2014-12-12,白云山公告,/disclosure/listedinfo/announcement/c/2014-12-11/600332_20141212_1.pdf
630,2014-12-18,白云山重大事项继续停牌并延期复牌的公告,/disclosure/listedinfo/announcement/c/2014-12-17/600332_20141218_1.pdf
631,2014-12-19,白云山关于控股股东修改承诺相关事项的公告,/disclosure/listedinfo/announcement/c/2014-12-18/600332_20141219_1.pdf
632,2014-12-20,白云山关于“王老吉红罐装潢纠纷案”判决结果的公告,/disclosure/listedinfo/announcement/c/2014-12-19/600332_20141220_1.pdf
633,2014-12-25,白云山重大事项继续停牌的公告,/disclosure/listedinfo/announcement/c/2014-12-24/600332_20141225_1.pdf
634,2014-12-25,白云山独立非执行董事辞职公告,/disclosure/listedinfo/announcement/c/2014-12-24/600332_20141225_3.pdf
635,2014-12-25,白云山第六届第七次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-24/600332_20141225_2.pdf
636,2015-01-01,白云山关于重大事项停牌进展公告,/disclosure/listedinfo/announcement/c/2014-12-31/600332_20150101_1.pdf
637,2015-01-10,白云山关于重大事项停牌进展公告,/disclosure/listedinfo/announcement/c/2015-01-09/600332_20150110_1.pdf
638,2015-01-13,白云山募集资金管理办法,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_23.pdf
639,2015-01-13,白云山截至2014年9月30日止的前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_7.pdf
640,2015-01-13,白云山截止至2014年9月30日前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_22.pdf
641,2015-01-13,白云山简式权益变动报告书（广州国资发展控股有限公司）,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_13.pdf
642,2015-01-13,白云山简式权益变动报告书（广州国寿城市发展产业投资企业（有限合伙））,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_12.pdf
643,2015-01-13,白云山监事会关于2015年度员工持股计划相关事项的审核意见,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_28.pdf
644,2015-01-13,白云山关于重大事项复牌提示性公告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_1.pdf
645,2015-01-13,白云山关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_5.pdf
646,2015-01-13,白云山关于控股股东修改承诺相关事项的公告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_8.pdf
647,2015-01-13,白云山关于公司与本次非公开发行对象签署《附条件生效的非公开发行A股股票认购协议》公告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_14.pdf
648,2015-01-13,白云山关于公司非公开发行股票涉及关联交易事项的公告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_4.pdf
649,2015-01-13,白云山关于非公开发行A股股票后填补被摊薄即期回报措施的公告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_6.pdf
650,2015-01-13,白云山关于本次非公开发行不涉及具有证券、期货从业资格的会计师事务所出具《审计报告》事项的说明,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_25.pdf
651,2015-01-13,白云山股东大会议事规则,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_20.pdf
652,2015-01-13,白云山公司章程,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_21.pdf
653,2015-01-13,白云山公告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_11.pdf
654,2015-01-13,白云山非公开发行A股股票预案,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_9.pdf
655,2015-01-13,白云山非公开发行A股股票募集资金使用可行性分析报告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_24.pdf
656,2015-01-13,白云山独立非执行董事提名人声明,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_15.pdf
657,2015-01-13,白云山独立董事候选人声明,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_16.pdf
658,2015-01-13,白云山独立董事关于公司第六届董事会第八次会议涉及关联交易相关事项的事前认可意见,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_17.pdf
659,2015-01-13,白云山独立董事关于第六届董事会第八次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_18.pdf
660,2015-01-13,白云山独立董事关于第六届董事会第八次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_19.pdf
661,2015-01-13,白云山第六届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_3.pdf
662,2015-01-13,白云山第六届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_2.pdf
663,2015-01-13,白云山：国浩律师（上海）事务所关于广州白云山医药集团股份有限公司实施员工持股计划之法律意见书,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_27.pdf
664,2015-01-13,白云山2015年度员工持股计划管理办法,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_29.pdf
665,2015-01-13,白云山2015年度员工持股计划（草案）摘要（认购非公开发行A股股票方式）,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_10.pdf
666,2015-01-13,白云山2015年度员工持股计划（草案）（认购非公开发行A股股票方式）,/disclosure/listedinfo/announcement/c/2015-01-12/600332_20150113_26.pdf
667,2015-01-15,白云山公告,/disclosure/listedinfo/announcement/c/2015-01-14/600332_20150115_1.pdf
668,2015-01-16,白云山澄清公告,/disclosure/listedinfo/announcement/c/2015-01-15/600332_20150116_1.pdf
669,2015-01-20,白云山关于召开2015年第一次内资股股东之类别股东大会的通知,/disclosure/listedinfo/announcement/c/2015-01-19/600332_20150120_2.pdf
670,2015-01-20,白云山关于召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-01-19/600332_20150120_1.pdf
671,2015-01-20,白云山关于召开2015年第一次境外上市外资股股东之类别股东大会的通知,/disclosure/listedinfo/announcement/c/2015-01-19/600332_20150120_3.pdf
672,2015-01-23,白云山关于召开2015年第一次临时股东大会、2015年第一次内资股股东之类别股东大会的补充公告,/disclosure/listedinfo/announcement/c/2015-01-22/600332_20150123_1.pdf
673,2015-01-23,白云山H股公告,/disclosure/listedinfo/announcement/c/2015-01-22/600332_20150123_2.pdf
674,2015-01-29,白云山关于2015年第一次临时股东大会、2015年第一次内资股股东之类别股东大会补充公告,/disclosure/listedinfo/announcement/c/2015-01-28/600332_20150129_1.pdf
675,2015-02-03,白云山H股公告,/disclosure/listedinfo/announcement/c/2015-02-02/600332_20150203_1.pdf
676,2015-02-26,白云山H股通函,/disclosure/listedinfo/announcement/c/2015-02-25/600332_20150226_1.pdf
677,2015-02-28,白云山关于“王老吉”商标法律纠纷的进展公告,/disclosure/listedinfo/announcement/c/2015-02-27/600332_20150228_1.pdf
678,2015-03-03,白云山公告,/disclosure/listedinfo/announcement/c/2015-03-02/600332_20150303_1.pdf
679,2015-03-10,白云山关于公司及下属企业通过高新技术企业认定的公告,/disclosure/listedinfo/announcement/c/2015-03-09/600332_20150310_1.pdf
680,2015-03-11,白云山2015年第一次临时股东大会暨类别股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-03-10/600332_20150311_1.pdf
681,2015-03-16,白云山临时停牌公告,/disclosure/listedinfo/announcement/c/2015-03-15/600332_20150316_1.pdf
682,2015-03-17,白云山继续停牌公告,/disclosure/listedinfo/announcement/c/2015-03-16/600332_20150317_1.pdf
683,2015-03-18,白云山复牌公告,/disclosure/listedinfo/announcement/c/2015-03-17/600332_20150318_4.pdf
684,2015-03-18,白云山第六届第九次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-17/600332_20150318_3.pdf
685,2015-03-18,白云山：北京市中伦（广州）律师事务所关于广州白云山医药集团股份有限公司修改公司章程的法律意见书,/disclosure/listedinfo/announcement/c/2015-03-17/600332_20150318_5.pdf
686,2015-03-18,白云山2015年第一次临时股东大会、2015年第一次内资股股东之类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-03-17/600332_20150318_1.pdf
687,2015-03-18,白云山2015年第一次临时股东大会、2015年第一次内资股股东之类别股东大会及2015年第一次境外上市外资股股东之类别股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-03-17/600332_20150318_6.pdf
688,2015-03-18,白云山2015年第一次境外上市外资股股东之类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-03-17/600332_20150318_2.pdf
689,2015-03-20,白云山向下属部分企业提供担保的公告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_3.pdf
690,2015-03-20,白云山年报摘要,/disclosure/listedinfo/announcement/c/2015-03-19/600332_2014_nzy.pdf
691,2015-03-20,白云山年报,/disclosure/listedinfo/announcement/c/2015-03-19/600332_2014_n.pdf
692,2015-03-20,白云山关于重大资产重组中所购买商标2014年度盈利预测实现情况的专项说明,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_17.pdf
693,2015-03-20,白云山关于重大资产重组中所购买房屋建筑物2014年度盈利预测实现情况的专项说明,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_16.pdf
694,2015-03-20,白云山独立董事关于累计和本报告期内担保情况的独立意见,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_6.pdf
695,2015-03-20,白云山独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_9.pdf
696,2015-03-20,白云山第六届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_2.pdf
697,2015-03-20,白云山第六届董事会辖下审核委员会履职情况汇总报告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_14.pdf
698,2015-03-20,白云山第六届第十次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_1.pdf
699,2015-03-20,白云山：关于公司盈利预测实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_15.pdf
700,2015-03-20,白云山：关于公司盈利预测实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_12.pdf
701,2015-03-20,白云山：关于对公司控股股东及其他关联方占用资金情况的专项审计说明,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_8.pdf
702,2015-03-20,白云山2014年度审计报告及财务报表,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_7.pdf
703,2015-03-20,白云山2014年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_11.pdf
704,2015-03-20,白云山2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_13.pdf
705,2015-03-20,白云山2014年度内部控制的自我评价报告,/disclosure/listedinfo/announcement/c/2015-03-19/600332_20150320_10.pdf
706,2015-03-21,白云山公告,/disclosure/listedinfo/announcement/c/2015-03-20/600332_20150321_1.pdf
707,2015-03-27,白云山公告,/disclosure/listedinfo/announcement/c/2015-03-26/600332_20150327_1.pdf
708,2015-04-01,白云山涉及仲裁进展公告,/disclosure/listedinfo/announcement/c/2015-03-31/600332_20150401_1.pdf
709,2015-04-18,白云山截至2014年12月31日止的前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2015-04-17/600332_20150418_2.pdf
710,2015-04-18,白云山第六届第十一次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-17/600332_20150418_1.pdf
711,2015-04-18,白云山2014年度前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-04-17/600332_20150418_3.pdf
712,2015-04-23,白云山公告,/disclosure/listedinfo/announcement/c/2015-04-22/600332_20150423_1.pdf
713,2015-04-24,白云山补充公告,/disclosure/listedinfo/announcement/c/2015-04-23/600332_20150424_1.pdf
714,2015-04-28,白云山日常关联交易公告,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_4.pdf
715,2015-04-28,白云山日常关联交易公告,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_5.pdf
716,2015-04-28,白云山关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_6.pdf
717,2015-04-28,白云山公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_10.pdf
718,2015-04-28,白云山独立董事制度,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_7.pdf
719,2015-04-28,白云山独立董事关于关联交易事项的意见（医药公司、和黄）,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_9.pdf
720,2015-04-28,白云山独立董事关于关联交易事项的意见（王老吉）,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_8.pdf
721,2015-04-28,白云山第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-27/600332_2015_1.pdf
722,2015-04-28,白云山第六届第十二次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_2.pdf
723,2015-04-28,白云山第六届第八次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_3.pdf
724,2015-04-28,白云山H股公告,/disclosure/listedinfo/announcement/c/2015-04-27/600332_20150428_11.pdf
725,2015-04-30,白云山关于日常关联交易的补充公告,/disclosure/listedinfo/announcement/c/2015-04-29/600332_20150430_1.pdf
726,2015-04-30,白云山关于日常关联交易的补充公告,/disclosure/listedinfo/announcement/c/2015-04-29/600332_20150430_2.pdf
727,2015-05-05,白云山重大事项进展公告,/disclosure/listedinfo/announcement/c/2015-05-04/600332_20150505_2.pdf
728,2015-05-05,白云山对外投资公告,/disclosure/listedinfo/announcement/c/2015-05-04/600332_20150505_1.pdf
729,2015-05-07,白云山涉及仲裁进展公告,/disclosure/listedinfo/announcement/c/2015-05-06/600332_20150507_2.pdf
730,2015-05-07,白云山关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-05-06/600332_20150507_1.pdf
731,2015-05-07,白云山关于股份回购实施结果及股份变动公告,/disclosure/listedinfo/announcement/c/2015-05-06/600332_20150507_5.pdf
732,2015-05-07,白云山公告,/disclosure/listedinfo/announcement/c/2015-05-06/600332_20150507_3.pdf
733,2015-05-07,白云山公告,/disclosure/listedinfo/announcement/c/2015-05-06/600332_20150507_4.pdf
734,2015-05-11,白云山公告,/disclosure/listedinfo/announcement/c/2015-05-10/600332_20150511_1.pdf
735,2015-05-14,白云山公告,/disclosure/listedinfo/announcement/c/2015-05-13/600332_20150514_1.pdf
736,2015-05-15,白云山关于签订《实施医药云商战略合作项目三方投资框架协议》的进展公告,/disclosure/listedinfo/announcement/c/2015-05-14/600332_20150515_1.pdf
737,2015-05-19,白云山公告,/disclosure/listedinfo/announcement/c/2015-05-18/600332_20150519_2.pdf
738,2015-05-19,白云山H股通函,/disclosure/listedinfo/announcement/c/2015-05-18/600332_20150519_1.pdf
739,2015-06-20,白云山2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-06-19/600332_20150620_1.pdf
740,2015-06-24,白云山公告,/disclosure/listedinfo/announcement/c/2015-06-23/600332_20150624_1.pdf
741,2015-06-27,白云山关于竞购广州医药研究总院有限公司100%股权的公告,/disclosure/listedinfo/announcement/c/2015-06-26/600332_20150627_1.pdf
742,2015-06-27,白云山2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-06-26/600332_20150627_2.pdf
743,2015-06-27,白云山2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-06-26/600332_20150627_3.pdf
744,2015-07-03,白云山公告,/disclosure/listedinfo/announcement/c/2015-07-02/600332_20150703_1.pdf
745,2015-07-04,白云山关于竞购广州医药研究总院有限公司100%股权的进展公告,/disclosure/listedinfo/announcement/c/2015-07-03/600332_20150704_1.pdf
746,2015-07-07,白云山公告,/disclosure/listedinfo/announcement/c/2015-07-06/600332_20150707_1.pdf
747,2015-07-07,白云山公告,/disclosure/listedinfo/announcement/c/2015-07-06/600332_20150707_2.pdf
748,2015-07-08,白云山关于竞购广州医药研究总院有限公司100%股权的摘牌公告,/disclosure/listedinfo/announcement/c/2015-07-07/600332_20150708_1.pdf
749,2015-07-09,白云山关于积极响应中国上市公司协会倡议的公告,/disclosure/listedinfo/announcement/c/2015-07-08/600332_20150709_1.pdf
750,2015-07-10,白云山关于签署《附条件生效的非公开发行A股股票认购协议之补充协议》的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_4.pdf
751,2015-07-10,白云山关于明确非公开发行A股股票募集资金投资项目具体投向和金额的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_3.pdf
752,2015-07-10,白云山关于公司最近五年被证券监管部门和交易所采取处罚或监管措施情况的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_5.pdf
753,2015-07-10,白云山关于非公开发行股票申请文件反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_6.pdf
754,2015-07-10,白云山关于非公开发行股票申请文件反馈意见的回复,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_17.pdf
755,2015-07-10,白云山关于非公开发行A股股票预案修订说明的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_18.pdf
756,2015-07-10,白云山非公开发行A股股票预案（修订稿）,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_7.pdf
757,2015-07-10,白云山非公开发行A股股票募集资金使用可行性分析报告（修订稿）,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_8.pdf
758,2015-07-10,白云山独立董事关于公司第六届董事会第十三次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_9.pdf
759,2015-07-10,白云山第六届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_2.pdf
760,2015-07-10,白云山：添富-定增盛世专户66号资产管理合同,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_10.pdf
761,2015-07-10,白云山：上海云锋新创股权投资中心（有限合伙）合伙协议,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_12.pdf
762,2015-07-10,白云山：广州国寿城市发展产业投资企业（有限合伙）之合伙协议,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_11.pdf
763,2015-07-10,白云山：承诺函（一）,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_13.pdf
764,2015-07-10,白云山：承诺函（四）,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_16.pdf
765,2015-07-10,白云山：承诺函（三）,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_15.pdf
766,2015-07-10,白云山：承诺函（二）,/disclosure/listedinfo/announcement/c/2015-07-09/600332_20150710_14.pdf
767,2015-07-28,白云山公告,/disclosure/listedinfo/announcement/c/2015-07-27/600332_20150728_1.pdf
768,2015-07-29,白云山对外投资公告,/disclosure/listedinfo/announcement/c/2015-07-28/600332_20150729_1.pdf
769,2015-07-31,白云山公告,/disclosure/listedinfo/announcement/c/2015-07-30/600332_20150731_1.pdf
770,2015-07-31,白云山2014年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2015-07-30/600332_20150731_2.pdf
771,2015-08-04,白云山公告,/disclosure/listedinfo/announcement/c/2015-08-04/600332_20150804_1.pdf
772,2015-08-15,白云山日常关联交易公告,/disclosure/listedinfo/announcement/c/2015-08-15/600332_20150815_4.pdf
773,2015-08-15,白云山独立董事关于关联交易事项的意见,/disclosure/listedinfo/announcement/c/2015-08-15/600332_20150815_7.pdf
774,2015-08-15,白云山独立董事关于2015年度日常关联交易的事前认可意见,/disclosure/listedinfo/announcement/c/2015-08-15/600332_20150815_6.pdf
775,2015-08-15,白云山第六届第十四次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-15/600332_20150815_2.pdf
776,2015-08-15,白云山第六届第九次监事会会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-15/600332_20150815_3.pdf
777,2015-08-15,白云山半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-15/600332_2015_zzy.pdf
778,2015-08-15,白云山半年报,/disclosure/listedinfo/announcement/c/2015-08-15/600332_2015_z.pdf
779,2015-08-20,白云山关于日常关联交易的补充公告,/disclosure/listedinfo/announcement/c/2015-08-20/600332_20150820_2.pdf
780,2015-08-20,白云山股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-08-20/600332_20150820_1.pdf
781,2015-08-20,白云山：回复函,/disclosure/listedinfo/announcement/c/2015-08-20/600332_20150820_3.pdf
782,2015-08-21,白云山关于签订《合作框架协议书》的公告,/disclosure/listedinfo/announcement/c/2015-08-21/600332_20150821_2.pdf
783,2015-08-21,白云山第六届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-21/600332_20150821_1.pdf
784,2015-08-29,白云山公告,/disclosure/listedinfo/announcement/c/2015-08-29/600332_20150829_1.pdf
785,2015-09-02,白云山公告,/disclosure/listedinfo/announcement/c/2015-09-02/600332_20150902_1.pdf
786,2015-09-25,白云山公告,/disclosure/listedinfo/announcement/c/2015-09-25/600332_20150925_1.pdf
787,2015-10-29,白云山关于实施2014年度利润分配方案后调整发行价格与发行数量及其调整非公开发行A股股票发行方案的公告,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_2.pdf
788,2015-10-29,白云山关于签署《附条件生效的非公开发行A股股票认购协议之补充协议》的公告,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_5.pdf
789,2015-10-29,白云山关于非公开发行股票申请文件反馈意见的回复之补充说明的公告,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_6.pdf
790,2015-10-29,白云山关于非公开发行股票申请文件反馈意见的回复之补充说明,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_10.pdf
791,2015-10-29,白云山关于非公开发行A股股票预案二次修订说明的公告,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_3.pdf
792,2015-10-29,白云山关于非公开发行A股股票后填补被摊薄即期回报措施的公告（修订稿）,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_4.pdf
793,2015-10-29,白云山非公开发行A股股票预案（二次修订稿）,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_8.pdf
794,2015-10-29,白云山非公开发行A股股票募集资金使用可行性分析报告（二次修订稿）,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_9.pdf
795,2015-10-29,白云山独立董事关于第六届董事会第十六次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_7.pdf
796,2015-10-29,白云山第六届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-10-29/600332_20151029_1.pdf
797,2015-10-30,白云山关于参与设立广州中以生物产业投资基金的公告,/disclosure/listedinfo/announcement/c/2015-10-30/600332_20151030_1.pdf
798,2015-10-31,白云山第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-31/600332_2015_3.pdf
799,2015-10-31,白云山第六届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-10-31/600332_20151031_2.pdf
800,2015-11-10,白云山公告,/disclosure/listedinfo/announcement/c/2015-11-10/600332_20151110_1.pdf
801,2015-11-27,白云山关于签署《附条件生效的非公开发行A股股票认购协议之补充协议》的公告,/disclosure/listedinfo/announcement/c/2015-11-27/600332_20151127_3.pdf
802,2015-11-27,白云山关于非公开发行A股股票预案三次修订说明的公告,/disclosure/listedinfo/announcement/c/2015-11-27/600332_20151127_2.pdf
803,2015-11-27,白云山非公开发行A股股票预案（三次修订稿）,/disclosure/listedinfo/announcement/c/2015-11-27/600332_20151127_5.pdf
804,2015-11-27,白云山独立董事关于第六届董事会第十八次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-11-27/600332_20151127_4.pdf
805,2015-11-27,白云山第六届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-11-27/600332_20151127_1.pdf
806,2015-12-01,白云山公告,/disclosure/listedinfo/announcement/c/2015-12-01/600332_20151201_1.pdf
807,2015-12-02,白云山澄清及复牌公告,/disclosure/listedinfo/announcement/c/2015-12-02/600332_20151202_1.pdf
808,2015-12-04,白云山公告,/disclosure/listedinfo/announcement/c/2015-12-04/600332_20151204_1.pdf
809,2015-12-05,白云山关于盐酸头孢替安酯片获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2015-12-05/600332_20151205_2.pdf
810,2015-12-05,白云山关于撤回依那普利非洛地平缓释片注册申请的公告,/disclosure/listedinfo/announcement/c/2015-12-05/600332_20151205_1.pdf
811,2015-12-10,白云山关于盐酸头孢替安酯片获得药物临床试验批件的补充公告,/disclosure/listedinfo/announcement/c/2015-12-10/600332_20151210_2.pdf
812,2015-12-10,白云山关于非公开发行A股股票申请获得中国证监会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2015-12-10/600332_20151210_1.pdf
813,2015-12-12,白云山关于全资子公司对外投资公告,/disclosure/listedinfo/announcement/c/2015-12-12/600332_20151212_1.pdf
814,2015-12-15,白云山关于设立广药白云山中医药国际化发展基金的公告,/disclosure/listedinfo/announcement/c/2015-12-15/600332_20151215_1.pdf
815,2015-12-16,白云山公告,/disclosure/listedinfo/announcement/c/2015-12-16/600332_20151216_1.pdf
816,2015-12-24,白云山公告,/disclosure/listedinfo/announcement/c/2015-12-24/600332_20151224_1.pdf
817,2015-12-29,白云山公告,/disclosure/listedinfo/announcement/c/2015-12-29/600332_20151229_1.pdf
818,2015-12-31,白云山关于全资子公司因政策性征拆涉及补偿事宜的公告,/disclosure/listedinfo/announcement/c/2015-12-31/600332_20151231_2.pdf
819,2015-12-31,白云山第六届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2015-12-31/600332_20151231_1.pdf
820,2016-01-01,白云山权限管理制度,/disclosure/listedinfo/announcement/c/2016-01-01/600332_20160101_2.pdf
821,2016-01-01,白云山董事会审核委员会实施细则,/disclosure/listedinfo/announcement/c/2016-01-01/600332_20160101_1.pdf
822,2016-01-14,白云山澄清公告,/disclosure/listedinfo/announcement/c/2016-01-14/600332_20160114_1.pdf
823,2016-01-15,白云山公告,/disclosure/listedinfo/announcement/c/2016-01-15/600332_20160115_1.pdf
824,2016-01-16,白云山关于非公开发行A股股票发行及授权延期的公告,/disclosure/listedinfo/announcement/c/2016-01-16/600332_20160116_3.pdf
825,2016-01-16,白云山独立董事关于公司第六届董事会第二十次会议涉及相关事项的事前认可意见,/disclosure/listedinfo/announcement/c/2016-01-16/600332_20160116_5.pdf
826,2016-01-16,白云山独立董事关于第六届董事会第二十次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-01-16/600332_20160116_4.pdf
827,2016-01-16,白云山第六届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2016-01-16/600332_20160116_2.pdf
828,2016-01-16,白云山补充公告,/disclosure/listedinfo/announcement/c/2016-01-16/600332_20160116_1.pdf
829,2016-01-19,白云山关于召开2016年第一次临时股东大会、2016年第一次内资股股东之类别股东大会的通知,/disclosure/listedinfo/announcement/c/2016-01-19/600332_20160119_1.pdf
830,2016-01-19,白云山关于召开2016年第一次境外上市外资股股东之类别股东大会的通知,/disclosure/listedinfo/announcement/c/2016-01-19/600332_20160119_2.pdf
831,2016-01-22,白云山公告,/disclosure/listedinfo/announcement/c/2016-01-22/600332_20160122_1.pdf
832,2016-01-27,白云山H股公告,/disclosure/listedinfo/announcement/c/2016-01-27/600332_20160127_1.pdf
833,2016-02-05,白云山监事辞任公告,/disclosure/listedinfo/announcement/c/2016-02-05/600332_20160205_1.pdf
834,2016-02-06,白云山H股通函,/disclosure/listedinfo/announcement/c/2016-02-06/600332_20160206_1.pdf
835,2016-02-16,白云山H股通函,/disclosure/listedinfo/announcement/c/2016-02-16/600332_20160216_1.pdf
836,2016-03-01,白云山关于头孢地尼分散片获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-03-01/600332_20160301_2.pdf
837,2016-03-01,白云山关于吉非替尼获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-03-01/600332_20160301_1.pdf
838,2016-03-02,白云山2016年第一次临时股东大会暨类别股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-03-02/600332_20160302_1.pdf
839,2016-03-08,白云山公告,/disclosure/listedinfo/announcement/c/2016-03-08/600332_20160308_1.pdf
840,2016-03-11,白云山2016年第一次临时股东大会、2016年第一次内资股股东之类别股东会决议公告,/disclosure/listedinfo/announcement/c/2016-03-11/600332_20160311_1.pdf
841,2016-03-11,白云山2016年第一次临时股东大会、2016年第一次内资股股东之类别股东大会及2016年第一次境外上市外资股股东之类别股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-03-11/600332_20160311_2.pdf
842,2016-03-11,白云山2016年第一次境外上市外资股股东之类别股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-03-11/600332_20160311_3.pdf
843,2016-03-19,白云山向属下部分企业提供银行综合授信额度担保的公告,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_5.pdf
844,2016-03-19,白云山审计报告及财务报表（2015年1月1日至2015年12月31日止）,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_7.pdf
845,2016-03-19,白云山年报摘要,/disclosure/listedinfo/announcement/c/2016-03-19/600332_2015_nzy.pdf
846,2016-03-19,白云山年报,/disclosure/listedinfo/announcement/c/2016-03-19/600332_2015_n.pdf
847,2016-03-19,白云山内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_13.pdf
848,2016-03-19,白云山关于累计和本报告期内担保情况的独立意见,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_18.pdf
849,2016-03-19,白云山关于2016年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_4.pdf
850,2016-03-19,白云山独立董事关于公司日常关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_16.pdf
851,2016-03-19,白云山独立董事关于公司第六届董事会第二十一次会议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_17.pdf
852,2016-03-19,白云山独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_9.pdf
853,2016-03-19,白云山第六届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_3.pdf
854,2016-03-19,白云山第六届董事会辖下审核委员会履职情况汇总报告,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_14.pdf
855,2016-03-19,白云山第六届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_1.pdf
856,2016-03-19,白云山：关于广州白云山医药集团股份有限公司盈利预测实现情况的专项审核报告（商标）,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_15.pdf
857,2016-03-19,白云山：关于广州白云山医药集团股份有限公司盈利预测实现情况的专项审核报告（房产）,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_12.pdf
858,2016-03-19,白云山：关于对广州白云山医药集团股份有限公司控股股东及其他关联方占用资金情况的专项审计说明,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_8.pdf
859,2016-03-19,白云山2015年度社会责任报告,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_11.pdf
860,2016-03-19,白云山2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-03-19/600332_20160319_10.pdf
861,2016-03-22,白云山年报（修订版）,/disclosure/listedinfo/announcement/c/2016-03-22/600332_2015_n.pdf
862,2016-03-22,白云山关于2015年年度报告的更正公告,/disclosure/listedinfo/announcement/c/2016-03-22/600332_20160322_1.pdf
863,2016-03-23,白云山与广州奥咨达医疗器械技术股份有限公司合作意向书,/disclosure/listedinfo/announcement/c/2016-03-23/600332_20160323_2.pdf
864,2016-03-23,白云山公告,/disclosure/listedinfo/announcement/c/2016-03-23/600332_20160323_1.pdf
865,2016-03-23,白云山：广州王老吉大健康产业有限公司与山西大寨饮品有限公司大寨核桃露项目合作意向书,/disclosure/listedinfo/announcement/c/2016-03-23/600332_20160323_3.pdf
866,2016-03-30,白云山关于开展治疗性双质粒HBV DNA疫苗IIc期临床研究的公告,/disclosure/listedinfo/announcement/c/2016-03-30/600332_20160330_1.pdf
867,2016-04-28,白云山修改公司章程公告,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_5.pdf
868,2016-04-28,白云山内幕信息知情人登记制度,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_13.pdf
869,2016-04-28,白云山监事会议事规则,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_11.pdf
870,2016-04-28,白云山关于全资子公司推进“三旧”改造事宜及所涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_4.pdf
871,2016-04-28,白云山股东提名董事候选人的程序,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_14.pdf
872,2016-04-28,白云山股东大会议事规则,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_9.pdf
873,2016-04-28,白云山公司章程（修订稿）,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_8.pdf
874,2016-04-28,白云山独立董事关于关联交易事项的独立意见,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_7.pdf
875,2016-04-28,白云山董事会议事规则（修订稿）,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_10.pdf
876,2016-04-28,白云山董事会秘书工作细则,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_12.pdf
877,2016-04-28,白云山第六届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_3.pdf
878,2016-04-28,白云山第六届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-28/600332_20160428_2.pdf
879,2016-04-28,白云山2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-28/600332_2016_1A.pdf
880,2016-04-28,白云山2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-28/600332_2016_1.pdf
881,2016-05-04,白云山关于非公开发行股票申请获得中国证监会核准的公告,/disclosure/listedinfo/announcement/c/2016-05-04/600332_20160504_1.pdf
882,2016-05-07,白云山关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-05-07/600332_20160507_1.pdf
883,2016-05-11,白云山公告,/disclosure/listedinfo/announcement/c/2016-05-11/600332_20160511_1.pdf
884,2016-05-13,白云山关于签署合作备忘录的公告,/disclosure/listedinfo/announcement/c/2016-05-13/600332_20160513_1.pdf
885,2016-05-18,白云山关于召开2015年度利润分配及现金分红网上投资者说明会预告的公告,/disclosure/listedinfo/announcement/c/2016-05-18/600332_20160518_1.pdf
886,2016-06-16,白云山2015年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-06-16/600332_20160616_1.pdf
887,2016-06-24,白云山2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-06-24/600332_20160624_1.pdf
888,2016-06-24,白云山2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-06-24/600332_20160624_2.pdf
889,2016-07-16,白云山关联交易公告,/disclosure/listedinfo/announcement/c/2016-07-16/600332_20160716_2.pdf
890,2016-07-16,白云山独立董事关于关联交易事项的独立意见,/disclosure/listedinfo/announcement/c/2016-07-16/600332_20160716_3.pdf
891,2016-07-16,白云山第六届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-16/600332_20160716_1.pdf
892,2016-07-20,白云山公告,/disclosure/listedinfo/announcement/c/2016-07-20/600332_20160720_2.pdf
893,2016-07-20,白云山澄清公告,/disclosure/listedinfo/announcement/c/2016-07-20/600332_20160720_1.pdf
894,2016-07-23,白云山关于控股股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2016-07-23/600332_20160723_1.pdf
895,2016-07-26,白云山关于确认2015年度员工持股计划认购规模的公告,/disclosure/listedinfo/announcement/c/2016-07-26/600332_20160726_3.pdf
896,2016-07-26,白云山关于开设募集资金专户的公告,/disclosure/listedinfo/announcement/c/2016-07-26/600332_20160726_2.pdf
897,2016-07-26,白云山第六届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-26/600332_20160726_1.pdf
898,2016-07-30,白云山关于媒体报道事项的进展公告,/disclosure/listedinfo/announcement/c/2016-07-30/600332_20160730_1.pdf
899,2016-08-18,白云山第六届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-18/600332_20160818_2.pdf
900,2016-08-18,白云山2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-18/600332_2016_zzy.pdf
901,2016-08-18,白云山2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-18/600332_2016_z.pdf
902,2016-08-19,白云山验资报告（截至2016年8月11日止）,/disclosure/listedinfo/announcement/c/2016-08-19/600332_20160819_3.pdf
903,2016-08-19,白云山简式权益变动报告书,/disclosure/listedinfo/announcement/c/2016-08-19/600332_20160819_6.pdf
904,2016-08-19,白云山关于非公开发行A股股票股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-19/600332_20160819_2.pdf
905,2016-08-19,白云山非公开发行A股股票发行情况报告书,/disclosure/listedinfo/announcement/c/2016-08-19/600332_20160819_5.pdf
906,2016-08-19,白云山非公开发行A股股票发行结果暨股份变动公告,/disclosure/listedinfo/announcement/c/2016-08-19/600332_20160819_1.pdf
907,2016-08-19,白云山：国浩律师（上海）事务所关于广州白云山医药集团股份有限公司非公开发行A股股票发行过程及认购对象合规性的法律意见书,/disclosure/listedinfo/announcement/c/2016-08-19/600332_20160819_4.pdf
908,2016-08-20,白云山：华泰联合证券有限责任公司、广州证券股份有限公司关于广州白云山医药集团股份有限公司非公开发行A股股票之发行过程和认购对象合规性报告,/disclosure/listedinfo/announcement/c/2016-08-20/600332_20160820_1.pdf
909,2016-08-30,白云山修改公司章程公告,/disclosure/listedinfo/announcement/c/2016-08-30/600332_20160830_5.pdf
910,2016-08-30,白云山关于签订《募集资金专户存储三方监管协议》的公告,/disclosure/listedinfo/announcement/c/2016-08-30/600332_20160830_3.pdf
911,2016-08-30,白云山关于调整2015年度非公开发行A股股票募集资金投资项目实际募集资金投入金额的公告,/disclosure/listedinfo/announcement/c/2016-08-30/600332_20160830_4.pdf
912,2016-08-30,白云山公司章程,/disclosure/listedinfo/announcement/c/2016-08-30/600332_20160830_8.pdf
913,2016-08-30,白云山独立董事关于公司调整2015年度非公开发行A股股票募集资金投资项目实际募集资金投入金额事项的独立意见,/disclosure/listedinfo/announcement/c/2016-08-30/600332_20160830_6.pdf
914,2016-08-30,白云山第六届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-30/600332_20160830_2.pdf
915,2016-08-30,白云山第六届董事会第二十六次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-30/600332_20160830_1.pdf
916,2016-08-30,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司调整2015年度非公开发行A股股票募集资金投资项目实际募集资金投入金额之核查意见,/disclosure/listedinfo/announcement/c/2016-08-30/600332_20160830_7.pdf
917,2016-09-01,白云山关于对第六届董事会第二十六次会议决议公告的补充公告,/disclosure/listedinfo/announcement/c/2016-09-01/600332_20160901_1.pdf
918,2016-09-06,白云山公告,/disclosure/listedinfo/announcement/c/2016-09-06/600332_20160906_1.pdf
919,2016-09-08,白云山监事辞任公告,/disclosure/listedinfo/announcement/c/2016-09-08/600332_20160908_1.pdf
920,2016-09-08,白云山关于职工监事任职的公告,/disclosure/listedinfo/announcement/c/2016-09-08/600332_20160908_2.pdf
921,2016-09-21,白云山公告,/disclosure/listedinfo/announcement/c/2016-09-21/600332_20160921_1.pdf
922,2016-09-23,白云山关于召开2016年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-09-23/600332_20160923_1.pdf
923,2016-10-12,白云山公告,/disclosure/listedinfo/announcement/c/2016-10-12/600332_20161012_1.pdf
924,2016-10-25,白云山非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2016-10-25/600332_20161025_1.pdf
925,2016-10-25,白云山：国泰君安证券股份有限公司关于广州白云山医药集团股份有限公司发行股份购买资产暨关联交易之限售股份上市流通的核查意见,/disclosure/listedinfo/announcement/c/2016-10-25/600332_20161025_2.pdf
926,2016-10-26,白云山第六届董事会第二十七次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-26/600332_20161026_2.pdf
927,2016-10-26,白云山2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-26/600332_2016_3.pdf
928,2016-11-03,白云山公告,/disclosure/listedinfo/announcement/c/2016-11-03/600332_20161103_1.pdf
929,2016-11-08,白云山2016年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-11-08/600332_20161108_1.pdf
930,2016-11-12,白云山2016年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-11-12/600332_20161112_1.pdf
931,2016-11-12,白云山2016年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-11-12/600332_20161112_2.pdf
932,2016-11-22,白云山2016年A股特别股息分派实施公告,/disclosure/listedinfo/announcement/c/2016-11-22/600332_20161122_1.pdf
933,2017-01-05,白云山关于以募集资金向全资子公司增资的公告,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_3.pdf
934,2017-01-05,白云山关于公司及全资子公司使用募集资金置换预先投入募集资金投资项目自筹资金的公告,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_4.pdf
935,2017-01-05,白云山关于参与认购云南鸿翔一心堂药业（集团）股份有限公司非公开发行A股股份的对外投资公告,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_6.pdf
936,2017-01-05,白云山独立董事关于公司第六届董事会第二十八次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_8.pdf
937,2017-01-05,白云山第六届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_2.pdf
938,2017-01-05,白云山第六届董事会第二十八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_1.pdf
939,2017-01-05,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司持续督导的现场检查报告,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_5.pdf
940,2017-01-05,白云山：华泰联合证券股份有限公司关于广州白云山医药集团股份有限公司以募集资金置换预先投入募投项目自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_9.pdf
941,2017-01-05,白云山：华泰联合证券股份有限公司关于广州白云山医药集团股份有限公司使用募集资金向子公司进行增资的核查意见,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_7.pdf
942,2017-01-05,白云山：2017年募集资金置换专项报告,/disclosure/listedinfo/announcement/c/2017-01-05/600332_20170105_10.pdf
943,2017-01-26,白云山关于签订募集资金专户存储四方监管协议的公告,/disclosure/listedinfo/announcement/c/2017-01-26/600332_20170126_1.pdf
944,2017-03-14,白云山澄清公告,/disclosure/listedinfo/announcement/c/2017-03-14/600332_20170314_1.pdf
945,2017-03-16,白云山向属下部分企业提供银行综合授信额度担保的公告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_4.pdf
946,2017-03-16,白云山关于本公司使用部分暂时闲置募集资金购买保本型结构性存款的公告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_6.pdf
947,2017-03-16,白云山关于2017年度日常关联交易预计数的公告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_3.pdf
948,2017-03-16,白云山关于2016年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_5.pdf
949,2017-03-16,白云山独立董事关于公司第六届董事会第二十九次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_13.pdf
950,2017-03-16,白云山独立董事关于公司第六届董事会第二十九次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_17.pdf
951,2017-03-16,白云山独立董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_20.pdf
952,2017-03-16,白云山第六届监事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_2.pdf
953,2017-03-16,白云山第六届董事会辖下审核委员会履职情况汇总报告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_22.pdf
954,2017-03-16,白云山第六届董事会第二十九次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_1.pdf
955,2017-03-16,白云山：审计报告及财务报表,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_18.pdf
956,2017-03-16,白云山：募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_15.pdf
957,2017-03-16,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司向属下部分企业提供银行综合授信额度担保事项的核查意见,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_9.pdf
958,2017-03-16,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司使用部分暂时闲置募集资金购买保本型结构性存款的核查意见,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_10.pdf
959,2017-03-16,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司2017年度日常关联交易预计事项的核查意见,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_8.pdf
960,2017-03-16,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司2016年度募集资金存放和使用情况专项核查报告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_12.pdf
961,2017-03-16,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司2016年度募集资金存放和使用情况专项核查报告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_14.pdf
962,2017-03-16,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司2016年持续督导年度报告书,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_11.pdf
963,2017-03-16,白云山：关于对广州白云山医药集团股份有限公司控股股东及其他关联方占用资金情况的专项审计说明,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_19.pdf
964,2017-03-16,白云山2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-03-16/600332_2016_nzy.pdf
965,2017-03-16,白云山2016年年度报告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_2016_n.pdf
966,2017-03-16,白云山2016年度社会责任报告,/disclosure/listedinfo/announcement/c/2017-03-16/600332_20170316_21.pdf
967,2017-03-17,白云山关于累计和本报告期内担保情况的独立意见,/disclosure/listedinfo/announcement/c/2017-03-17/600332_20170317_1.pdf
968,2017-03-29,白云山公告,/disclosure/listedinfo/announcement/c/2017-03-29/600332_20170329_1.pdf
969,2017-04-08,白云山澄清公告,/disclosure/listedinfo/announcement/c/2017-04-08/600332_20170408_1.pdf
970,2017-04-27,白云山关于董事会秘书辞职与聘任董事会秘书的公告,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_1.pdf
971,2017-04-27,白云山关于变更公司联系方式的公告,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_2.pdf
972,2017-04-27,白云山关于本公司使用部分暂时闲置募集资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_7.pdf
973,2017-04-27,白云山关于本公司及其附属企业使用部分暂时闲置自有资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_8.pdf
974,2017-04-27,白云山独立董事提名人声明,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_13.pdf
975,2017-04-27,白云山独立董事候选人声明（王卫红）,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_17.pdf
976,2017-04-27,白云山独立董事候选人声明（姜文奇）,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_16.pdf
977,2017-04-27,白云山独立董事候选人声明（黄显荣）,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_15.pdf
978,2017-04-27,白云山独立董事候选人声明（储小平）,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_14.pdf
979,2017-04-27,白云山独立董事关于聘任董事会秘书的独立意见,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_12.pdf
980,2017-04-27,白云山独立董事关于公司第六届董事会第三十次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_10.pdf
981,2017-04-27,白云山独立董事关于董事会换届选举的独立意见,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_11.pdf
982,2017-04-27,白云山第六届监事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_6.pdf
983,2017-04-27,白云山第六届董事会第三十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_5.pdf
984,2017-04-27,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2017-04-27/600332_20170427_3.pdf
985,2017-04-27,白云山2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-27/600332_2017_1.pdf
986,2017-04-28,白云山关于2017年第一季度报告更正公告,/disclosure/listedinfo/announcement/c/2017-04-28/600332_20170428_1.pdf
987,2017-04-28,白云山2017年第一季度报告（修订稿）,/disclosure/listedinfo/announcement/c/2017-04-28/600332_2017_1.pdf
988,2017-05-09,白云山关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-09/600332_20170509_1.pdf
989,2017-05-09,白云山H股股东通函,/disclosure/listedinfo/announcement/c/2017-05-09/600332_20170509_2.pdf
990,2017-05-23,白云山关于枸橼酸西地那非片获得药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2017-05-23/600332_20170523_1.pdf
991,2017-06-08,白云山关于2016年年度股东大会取消部分议案的公告,/disclosure/listedinfo/announcement/c/2017-06-08/600332_20170608_1.pdf
992,2017-06-12,白云山关于2016年年度股东大会取消部分议案的公告的补充公告,/disclosure/listedinfo/announcement/c/2017-06-12/600332_20170612_1.pdf
993,2017-06-15,白云山关于使用部分暂时闲置募集资金购买保本型结构性存款的进展公告,/disclosure/listedinfo/announcement/c/2017-06-15/600332_20170615_1.pdf
994,2017-06-17,白云山关于使用部分暂时闲置募集资金购买保本型结构性存款的进展公告的更正公告,/disclosure/listedinfo/announcement/c/2017-06-17/600332_20170617_1.pdf
995,2017-06-17,白云山2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-06-17/600332_20170617_2.pdf
996,2017-06-21,白云山关于职工监事任职的公告,/disclosure/listedinfo/announcement/c/2017-06-21/600332_20170621_1.pdf
997,2017-06-24,白云山2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-24/600332_20170624_1.pdf
998,2017-06-24,白云山2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-24/600332_20170624_2.pdf
999,2017-06-27,白云山关于聘任总经理的公告,/disclosure/listedinfo/announcement/c/2017-06-27/600332_20170627_5.pdf
1000,2017-06-27,白云山关于聘任副总经理的公告,/disclosure/listedinfo/announcement/c/2017-06-27/600332_20170627_6.pdf
1001,2017-06-27,白云山关于聘任董事会秘书与证券事务代表的公告,/disclosure/listedinfo/announcement/c/2017-06-27/600332_20170627_7.pdf
1002,2017-06-27,白云山独立董事关于聘任董事会秘书的独立意见,/disclosure/listedinfo/announcement/c/2017-06-27/600332_20170627_3.pdf
1003,2017-06-27,白云山独立董事关于公司第七届董事会第一次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-06-27/600332_20170627_2.pdf
1004,2017-06-27,白云山第七届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-06-27/600332_20170627_4.pdf
1005,2017-06-27,白云山第七届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-06-27/600332_20170627_1.pdf
1006,2017-06-27,白云山H股公告,/disclosure/listedinfo/announcement/c/2017-06-27/600332_20170627_8.pdf
1007,2017-06-29,白云山关于华佗再造丸等75个品种获得药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2017-06-29/600332_20170629_1.pdf
1008,2017-07-04,白云山：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-07-04/600332_20170704_2.pdf
1009,2017-07-04,白云山2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-07-04/600332_20170704_1.pdf
1010,2017-07-11,白云山2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-07-11/600332_20170711_1.pdf
1011,2017-07-25,白云山对外投资进展公告,/disclosure/listedinfo/announcement/c/2017-07-25/600332_20170725_1.pdf
1012,2017-07-29,白云山关于控股股东部分股份解除质押的公告,/disclosure/listedinfo/announcement/c/2017-07-29/600332_20170729_1.pdf
1013,2017-08-01,白云山关于控股股东部分股份解除质押的公告,/disclosure/listedinfo/announcement/c/2017-08-01/600332_20170801_1.pdf
1014,2017-08-03,白云山关于变更募投项目实施地点的公告,/disclosure/listedinfo/announcement/c/2017-08-03/600332_20170803_4.pdf
1015,2017-08-03,白云山独立董事意见,/disclosure/listedinfo/announcement/c/2017-08-03/600332_20170803_2.pdf
1016,2017-08-03,白云山第七届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-03/600332_20170803_3.pdf
1017,2017-08-03,白云山第七届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-03/600332_20170803_1.pdf
1018,2017-08-03,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司变更募投项目实施地点的核查意见,/disclosure/listedinfo/announcement/c/2017-08-03/600332_20170803_5.pdf
1019,2017-08-04,白云山关于注射用头孢唑肟钠获得药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2017-08-04/600332_20170804_1.pdf
1020,2017-08-11,白云山关于全资子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-08-11/600332_20170811_1.pdf
1021,2017-08-12,白云山关于完成注册资本工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-08-12/600332_20170812_1.pdf
1022,2017-08-12,白云山关于全资子公司获得药品GMP证书的补充公告,/disclosure/listedinfo/announcement/c/2017-08-12/600332_20170812_2.pdf
1023,2017-08-17,白云山关于“王老吉红罐装潢纠纷案”终审判决结果的公告,/disclosure/listedinfo/announcement/c/2017-08-17/600332_20170817_1.pdf
1024,2017-08-21,白云山关于2017年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-21/600332_20170821_7.pdf
1025,2017-08-21,白云山独立董事关于2017年半年度募集资金存放与实际使用情况的专项报告的意见函,/disclosure/listedinfo/announcement/c/2017-08-21/600332_20170821_5.pdf
1026,2017-08-21,白云山独立董事关于2017年半年度财务报告中主要会计政策与会计估计内容修订的意见函,/disclosure/listedinfo/announcement/c/2017-08-21/600332_20170821_4.pdf
1027,2017-08-21,白云山第七届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-21/600332_20170821_6.pdf
1028,2017-08-21,白云山第七届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-21/600332_20170821_3.pdf
1029,2017-08-21,白云山H股公告,/disclosure/listedinfo/announcement/c/2017-08-21/600332_20170821_8.pdf
1030,2017-08-21,白云山2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-21/600332_2017_zzy.pdf
1031,2017-08-21,白云山2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-21/600332_2017_z.pdf
1032,2017-08-29,白云山关于董事辞任的公告,/disclosure/listedinfo/announcement/c/2017-08-29/600332_20170829_1.pdf
1033,2017-08-29,白云山H股公告,/disclosure/listedinfo/announcement/c/2017-08-29/600332_20170829_2.pdf
1034,2017-09-14,白云山澄清公告,/disclosure/listedinfo/announcement/c/2017-09-14/600332_20170914_1.pdf
1035,2017-09-27,白云山关于获得广东省食品药品监督管理局同意开展中药配方颗粒省内试点研究的批复的公告,/disclosure/listedinfo/announcement/c/2017-09-27/600332_20170927_1.pdf
1036,2017-10-11,白云山关于全资子公司获得药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2017-10-11/600332_20171011_1.pdf
1037,2017-10-23,白云山关于公司新增募集资金投资项目实施主体的公告,/disclosure/listedinfo/announcement/c/2017-10-23/600332_20171023_6.pdf
1038,2017-10-23,白云山独立董事关于公司新增募集资金投资项目实施主体的独立意见,/disclosure/listedinfo/announcement/c/2017-10-23/600332_20171023_4.pdf
1039,2017-10-23,白云山第七届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-23/600332_20171023_5.pdf
1040,2017-10-23,白云山第七届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-23/600332_20171023_3.pdf
1041,2017-10-23,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司新增募集资金投资项目实施主体的核查意见,/disclosure/listedinfo/announcement/c/2017-10-23/600332_20171023_7.pdf
1042,2017-10-23,白云山2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-23/600332_2017_3.pdf
1043,2017-10-27,白云山关于控股子公司药品生产许可证变更的公告,/disclosure/listedinfo/announcement/c/2017-10-27/600332_20171027_1.pdf
1044,2017-10-31,白云山重大事项停牌公告,/disclosure/listedinfo/announcement/c/2017-10-31/600332_20171031_1.pdf
1045,2017-10-31,白云山澄清公告,/disclosure/listedinfo/announcement/c/2017-10-31/600332_20171031_2.pdf
1046,2017-11-02,白云山对外投资进展公告,/disclosure/listedinfo/announcement/c/2017-11-02/600332_20171102_1.pdf
1047,2017-11-04,白云山关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-11-04/600332_20171104_1.pdf
1048,2017-11-07,白云山重大事项停牌进展公告,/disclosure/listedinfo/announcement/c/2017-11-07/600332_20171107_1.pdf
1049,2017-11-14,白云山重大资产重组停牌公告,/disclosure/listedinfo/announcement/c/2017-11-14/600332_20171114_1.pdf
1050,2017-11-14,白云山关于公司前十大股东持股情况的公告,/disclosure/listedinfo/announcement/c/2017-11-14/600332_20171114_2.pdf
1051,2017-11-15,白云山公告,/disclosure/listedinfo/announcement/c/2017-11-15/600332_20171115_1.pdf
1052,2017-11-18,白云山关于收到上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2017-11-18/600332_20171118_1.pdf
1053,2017-11-21,白云山重大资产重组停牌进展公告,/disclosure/listedinfo/announcement/c/2017-11-21/600332_20171121_1.pdf
1054,2017-11-24,白云山关于上海证券交易所问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-11-24/600332_20171124_1.pdf
1055,2017-11-25,白云山关于控股子公司药品生产许可证变更的公告,/disclosure/listedinfo/announcement/c/2017-11-25/600332_20171125_1.pdf
1056,2017-11-28,白云山重大资产重组停牌进展公告,/disclosure/listedinfo/announcement/c/2017-11-28/600332_20171128_2.pdf
1057,2017-11-28,白云山关于控股子公司签订战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2017-11-28/600332_20171128_1.pdf
1058,2017-11-30,白云山重大资产重组停牌进展暨延期复牌公告,/disclosure/listedinfo/announcement/c/2017-11-30/600332_20171130_1.pdf
1059,2017-12-05,白云山重大资产重组停牌进展公告,/disclosure/listedinfo/announcement/c/2017-12-05/600332_20171205_1.pdf
1060,2017-12-12,白云山重大资产重组停牌进展公告,/disclosure/listedinfo/announcement/c/2017-12-12/600332_20171212_1.pdf
1061,2017-12-12,白云山关于全资子公司获得商标注册证书的公告,/disclosure/listedinfo/announcement/c/2017-12-12/600332_20171212_2.pdf
1062,2017-12-13,白云山关于使用部分暂时闲置募集资金购买保本型结构性存款的进展公告,/disclosure/listedinfo/announcement/c/2017-12-13/600332_20171213_1.pdf
1063,2017-12-15,白云山2017年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-12-15/600332_20171215_1.pdf
1064,2017-12-16,白云山关于使用部分暂时闲置募集资金购买保本型结构性存款的进展公告,/disclosure/listedinfo/announcement/c/2017-12-16/600332_20171216_1.pdf
1065,2017-12-19,白云山重大资产重组停牌进展公告,/disclosure/listedinfo/announcement/c/2017-12-19/600332_20171219_1.pdf
1066,2017-12-23,白云山重大资产购买报告书（摘要）,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_6.pdf
1067,2017-12-23,白云山重大资产购买报告书,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_7.pdf
1068,2017-12-23,白云山拟实施股权收购所涉及广州医药有限公司的股东全部权益资产评估说明,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_19.pdf
1069,2017-12-23,白云山拟实施股权收购所涉及广州医药有限公司的股东全部权益资产评估报告,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_10.pdf
1070,2017-12-23,白云山关于使用部分暂时闲置募集资金购买保本型结构性理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_22.pdf
1071,2017-12-23,白云山关于披露重大资产购买报告书暨公司A股股票继续停牌的公告,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_5.pdf
1072,2017-12-23,白云山关于本次重大资产重组前12个月内购买、出售资产的说明,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_13.pdf
1073,2017-12-23,白云山独立董事关于公司重大资产购买的事前认可意见,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_3.pdf
1074,2017-12-23,白云山独立董事关于公司重大资产购买的独立意见,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_2.pdf
1075,2017-12-23,白云山董事会关于公司股票价格波动未达到《关于规范上市公司信息披露及相关各方行为的通知》第五条相关标准的说明,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_16.pdf
1076,2017-12-23,白云山董事会关于本次交易符合《关于规范上市公司重大资产重组若干问题的规定》第四条规定的说明,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_15.pdf
1077,2017-12-23,白云山董事关于本次交易履行法定程序的完备性、合规性及提交法律文件的有效性的说明,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_14.pdf
1078,2017-12-23,白云山第七届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_4.pdf
1079,2017-12-23,白云山第七届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_1.pdf
1080,2017-12-23,白云山：中信证券股份有限公司关于广州白云山医药集团股份有限公司本次重大资产重组前12个月内购买、出售资产的核查意见,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_17.pdf
1081,2017-12-23,白云山：中信证券股份有限公司关于白云山重大资产购买报告书之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_8.pdf
1082,2017-12-23,白云山：中信证券股份有限公司关于《广州白云山医药集团股份有限公司关于重大资产重组信息公布前股票价格波动未达到＜关于规范上市公司信息披露及相关各方行为的通知＞第五条相关标准的说明》的核查意见,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_18.pdf
1083,2017-12-23,白云山：审阅报告及备考财务报表,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_12.pdf
1084,2017-12-23,白云山：国浩律师（上海）事务所关于广州白云山医药集团股份有限公司重大资产购买之法律意见书,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_11.pdf
1085,2017-12-23,白云山：广州医药有限公司审计报告,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_9.pdf
1086,2017-12-23,白云山2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_20.pdf
1087,2017-12-23,白云山2017年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-12-23/600332_20171223_21.pdf
1088,2017-12-26,白云山涉及仲裁结果的公告,/disclosure/listedinfo/announcement/c/2017-12-26/600332_20171226_2.pdf
1089,2017-12-26,白云山澄清公告,/disclosure/listedinfo/announcement/c/2017-12-26/600332_20171226_1.pdf
1090,2017-12-27,白云山澄清公告的补充公告,/disclosure/listedinfo/announcement/c/2017-12-27/600332_20171227_2.pdf
1091,2017-12-27,白云山：华泰联合证券有限责任公司关于广州白云山医药集团股份有限公司持续督导的现场检查报告,/disclosure/listedinfo/announcement/c/2017-12-27/600332_20171227_1.pdf
1092,2018-01-02,白云山关于收到上海证券交易所对重大资产购买报告书信息披露的问询函的公告,/disclosure/listedinfo/announcement/c/2018-01-02/600332_20180102_2.pdf
1093,2018-01-02,白云山关于获得1类化学新药头孢嗪脒钠药物临床试验批件和审批意见通知件的公告,/disclosure/listedinfo/announcement/c/2018-01-02/600332_20180102_1.pdf
1094,2018-01-05,白云山关于子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2018-01-05/600332_20180105_1.pdf
1095,2018-01-06,白云山重大资产购买报告书（修订稿）,/disclosure/listedinfo/announcement/c/2018-01-06/600332_20180106_2.pdf
1096,2018-01-06,白云山关于重大资产重组复牌的提示性公告,/disclosure/listedinfo/announcement/c/2018-01-06/600332_20180106_6.pdf
1097,2018-01-06,白云山对上海证券交易所《关于对广州白云山医药集团股份有限公司重大资产购买报告书信息披露的问询函》的回复公告,/disclosure/listedinfo/announcement/c/2018-01-06/600332_20180106_1.pdf
1098,2018-01-06,白云山：中信证券股份有限公司关于《广州白云山医药集团股份有限公司对上海证券交易所＜关于对广州白云山医药集团股份有限公司重大资产购买报告书信息披露的问询函＞的回复》之核查意见,/disclosure/listedinfo/announcement/c/2018-01-06/600332_20180106_3.pdf
1099,2018-01-06,白云山：立信会计师事务所（特殊普通合伙）关于上海证券交易所对白云山重大资产购买报告书信息披露的问询函的回复,/disclosure/listedinfo/announcement/c/2018-01-06/600332_20180106_5.pdf
1100,2018-01-06,白云山：毕马威华振会计师事务所（特殊普通合伙）关于《对广州白云山医药集团股份有限公司重大资产购买报告书信息披露的问询函》有关财务事项说明,/disclosure/listedinfo/announcement/c/2018-01-06/600332_20180106_4.pdf
1101,2018-01-30,白云山关于诉讼结果的公告,/disclosure/listedinfo/announcement/c/2018-01-30/600332_20180130_1.pdf
1102,2018-02-10,白云山关于召开2018年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2018-02-10/600332_20180210_1.pdf
1103,2018-02-10,白云山H股通函,/disclosure/listedinfo/announcement/c/2018-02-10/600332_20180210_2.pdf
1104,2018-02-14,白云山关于参与设立股权投资基金管理公司及医药健康产业投资基金暨关联交易的公告,/disclosure/listedinfo/announcement/c/2018-02-14/600332_20180214_4.pdf
1105,2018-02-14,白云山关于参与设立股权投资基金管理公司及医药健康产业投资基金的公告,/disclosure/listedinfo/announcement/c/2018-02-14/600332_20180214_3.pdf
1106,2018-02-14,白云山独立董事意见,/disclosure/listedinfo/announcement/c/2018-02-14/600332_20180214_2.pdf
1107,2018-02-14,白云山第七届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2018-02-14/600332_20180214_1.pdf
